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1 SUMMARY 
Second messengers exist in all domains of life to amplify and transduce 
external stimuli inside the cell. Recently, a new second messenger molecule was 
identified in bacteria: Cyclic di-AMP. C-di-AMP is synthesized in many bacterial 
species by different enzymes containing a DAC domain. These enzymes are regulated 
in response to DNA damage, sporulation and other, so far unidentified events. 
Subsequently, c-di-AMP is sensed by various receptors, such as ion channels, a 
transcription factor, a transcription factor regulator, a metabolic enzyme, a riboswitch 
and other, less well-characterized, proteins. The intracellular pool of c-di-AMP is 
adjusted not only by regulated synthesis, but also by degradation through different 
classes of phosphodiesterases. These enzymes are regulated by small molecules 
including Heme and the starvation signal (p)ppGpp. C-di-AMP was shown to influence 
a variety of important cellular processes: For example, sporulating bacteria depend on 
c-di-AMP signaling to produce viable spores upon DNA damage. Furthermore, 
potassium homeostasis, cell wall- and membrane metabolism are regulated by this 
second messenger. Most importantly, c-di-AMP was shown to be essential in almost all 
species studied so far and to influence the susceptibility or resistance to cell wall 
targeting antibiotics. Moreover, c-di-AMP is sensed by the mammalian innate immune 
system and triggers defense mechanisms against bacteria. As a consequence c-di-AMP 
pathways are not only interesting from the microbiological point of view, but also for 
the development of new antimicrobial drugs. 
In order to gain insights into the synthesis of this new second messenger, the 
reaction mechanism of c-di-AMP synthesis by the DAC prototype DisA was studied. 
The protein was crystallized in the nucleotide-free state, in complex with different 
substrate analogs representing reaction intermediates, and in the product state. 
Additionally, manganese ions were added to identify the binding site of the metal ion 
essential for catalysis. With the resulting crystal structures as well as biochemical 
analysis, the coordination and activation of the substrate ATP necessary to perform 
the cyclase reaction were elucidated. The high conservation of the catalytically 
essential amino acids gives strong evidence that the reaction mechanism is universal 
for all DAC domain proteins. As c-di-AMP is essential and both increased as well as 
decreased levels of this second messenger lead to severe phenotypes, DAC enzymes 
are promising new targets for antimicrobial therapy. Interestingly, the commercially 
available non-reactive substrate analog 3′-dATP was found to act as a potent inhibitor 
of DisA. This ATP analog is certainly not a specific DisA inhibitor; however, it was 
shown to provide not only antimicrobial activity but is also being tested in therapy of 
cancer and inflammatory diseases. 
Alongside the investigation of c-di-AMP synthesis, the receptor PstA was 
analyzed. PstA binds c-di-AMP selectively and with high affinity. Additional structural 
investigation revealed that the protein is distantly related to the widely spread class of 
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PII signal transduction proteins. However, due to structural differences, ligand binding 
differs between PstA and canonical PII proteins and the mode of action of PstA in 
signal transduction still remains elusive. Nevertheless, PstA occurs in numerous 
bacterial species and is likely to have an important function in c-di-AMP signaling. 
The role of c-di-AMP signaling is still far from being understood, even though 
it has become an active field of research in recent years. Future work will reveal not 
only which cellular processes are regulated and why this second messenger is 
essential, but also how this knowledge can be applied in the development of new 
antimicrobial drugs. 
 
  
Figure 1: Overview on bacterial c-di-AMP pathways identified and characterized in different bacterial 
species. C-di-AMP synthases (blue), receptors (green) and phosphodiesterases (brown) are depicted. 
Explanation of acronyms: PC = pyruvate carboxylase; aa = amino acid; PDE = phosphodiesterase 
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2 INTRODUCTION 
In order to react to their environment, living organisms need to sense external 
factors such as nutrients, light or temperature. The signals from these first 
messengers are then transduced and amplified inside the cell by production of second 
messenger molecules. Subsequently, the second messengers initiate a signal cascade, 
resulting finally in a specific output such as motility, metabolic changes or sporulation. 
In bacteria, there exist different types of second messengers: nucleotide-derived 
molecules and substances such as nitric oxide or calcium-ions. These diffuse rapidly 
through the cell and allow for a large variety of processes being specifically and 
expeditiously regulated [1]. 
2.1 BACTERIAL NUCLEOTIDE SECOND MESSENGERS 
Aside from cyclic di-AMP, which will be described in detail later on, several 
other nucleotide-derived second messengers occur in bacteria, some of them well 
known for decades. Their diverse functions and associated signaling pathways are 
briefly described in the following chapters. 
 
 
 
Figure 2: Overview on bacterial nucleotide second messengers and processes they regulate. 
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Figure 3: Cyclic AMP 
2.1.1 CYCLIC AMP 
Cyclic AMP (cAMP, Figure 3) was the first nucleotide 
second messenger to be described already in 1958 [2] and its 
diverse functions in eukaryotes as well as in bacteria have 
been studied in great detail since then. Most bacteria, but not 
all (e.g. Bacillus subtilis), produce cAMP. The second 
messenger is not essential; however, mutants lacking cAMP 
are impaired in growth or development. cAMP is synthesized 
by adenylyl  cyclases organized in different classes: while 
class III comprises a large variety of enzymes and is found in 
all kingdoms of life, classes I, II and IV are exclusively present in bacteria and play 
important roles for example in catabolite repression, biofilm formation and virulence. 
As diverse as the pathways adenylyl cyclases are involved in, are their structures. The 
enzymes are either monomeric or dimeric with one or two active sites and sometimes 
additional ligand binding sites and regulatory domains. Moreover, the cyclases are 
either soluble, associated to the cell membrane or are even integral membrane 
proteins. The intracellular levels of cAMP are regulated by three different 
mechanisms. The adenylyl cyclase’s activity itself is modulated on the transcriptional 
level, via covalent modifications or by interactions with other proteins or small 
molecules (e.g. Ca2+ or CO2). Secondly, the degradation of cAMP by phosphodiesterases 
(PDE) is tightly regulated, and thirdly, cAMP is secreted to the medium to a large 
extend (reviewed in [3]). 
Two prominent examples of bacterial cAMP pathways shall illustrate the 
diversity of mechanisms regulated by this second messenger. One of the most well-
known pathways dependent on cAMP is carbon catabolite repression in Escherichia 
coli. When high levels of glucose are present in the cell, the ratio between 
phosphoenolpyruvate and pyruvate is low, leading to dephosphorylation of the 
glucose specific phosphotransferase system EIIAGlc. Dephosphorylated EIIAGlc binds to 
and thereby inactivates metabolic enzymes and transporters of secondary carbon 
sources. However, when the intracellular glucose concentration decreases EIIAGlc gets 
phosphorylated and activates CyaA, a membrane bound class I adenylate cyclase. 
CyaA then produces cAMP which is sensed by the transcription activator CRP. The 
CRP-cAMP complex finally activates promoters of different catabolic genes and 
operons such as the lac operon required for secondary carbon source metabolism 
(reviewed in [4]). 
Some pathogenic bacteria are able to interfere with their host’s cAMP 
signaling pathways to suppress the immune response and facilitate their propagation. 
Bacteria either directly secrete cAMP into the host cells (e.g. Mycobacterium 
tuberculosis), export toxins, which activate adenylate cyclases of the host (e.g. Vibrio 
cholerae), or secrete adenylate cyclases of class II, which are active in the host’s cells 
(e.g. Bacillus anthracis). B. anthracis produces the oedema factor toxin, which is a 
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Figure 4: (p)ppGpp 
calmodulin-dependent adenylate cyclase. With the help of an additional toxin, the 
oedema factor is first taken up endocytotically by the host cell and then released from 
the endosome into the cytosol, where it binds calmoduline and thereupon produces 
cAMP. The resulting increase in cAMP levels interferes with the host cell’s bactericidal 
functions and is therefore an important virulence factor of B. anthracis (reviewed in 
[5] and [6]). 
2.1.2 (P)PPGPP 
GDP-3′-diphosphate and GTP-
3′-diphosphate ((p)ppGpp, Figure 4) 
were initially identified 1969 in E. coli 
responding to amino acid starvation [7] 
and were subsequently found to signal 
the lack of other nutrients like 
phosphate, fatty acids, carbon and iron 
as well. (p)ppGpp influences numerous 
cellular processes such as transcription, 
translation, replication and the 
metabolism and thereby triggers the ‘stringent response’, allowing the cell to survive 
under and adapt to unfavorable conditions, for example by reduction of the growth 
rate. Nevertheless, knockouts of (p)ppGpp synthases are possible, therefore this 
second messenger is not essential, but the cells depend on it to correctly respond to 
different stresses. 
Synthesis and degradation of (p)ppGpp are performed by three classes of 
proteins, which co-exist in many bacteria: RelA/SpoT homologous proteins (RSH) 
comprise two domains, one for synthesis of (p)ppGpp and one for its hydrolysis, while 
small alarmone synthases contain only the synthase domain and small alarmone 
hydrolases only degrade (p)ppGpp. These three protein classes are regulated in their 
activity by different mechanisms. E. coli RelA for example senses amino acid 
starvation directly by interacting with an uncharged tRNA bound to the A-site of the 
ribosome and thereupon synthesizes (p)ppGpp. (p)ppGpp then binds to the RNA 
polymerase and acts as an allosteric regulator, activating transcription of genes 
essential for amino acid synthesis, while inhibiting transcription of e.g. rRNA and 
tRNA. Besides the multiple metabolic processes regulated by (p)ppGpp, it also plays a 
role in antibiotic resistance. Expression of small alarmone synthase proteins e.g. from 
B. subtilis or Staphylococcus aureus is strongly induced by antibiotics targeting cell 
wall synthesis such as ampicillin and vancomycin, at the same time lack of (p)ppGpp 
renders bacteria more sensitive towards antibiotics (reviewed in [8] and [9]). 
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Figure 5: Cyclic di-GMP 
2.1.3 CYCLIC DI-GMP 
Cyclic di-GMP (c-di-GMP, Figure 5) was discovered in 1987 as an activator of a 
bacterial cellulose synthase [10]; however, the main function of this second 
messenger was found to be the regulation of the transition from single motile cells to 
biofilms. This change is achieved by reduction of motility, while adhesion to surfaces 
and polysaccharide production to form the biofilm matrix are increased.  
Synthesis and degradation of c-
di-GMP are regulated in response to 
external stimuli such as oxygen, nitric 
oxide, light and nutrients, which are 
sensed by regulatory domains 
connected to c-di-GMP synthases and 
hydrolases. Diguanylate cyclases (DGC) 
contain a catalytically active GGDEF or 
GGEEF domain with highly conserved 
active site residues. Regulation of DGC 
often occurs via product inhibition: the 
enzyme contains an additional 
inhibitory site c-di-GMP can bind to and thereby allosterically inhibits c-di-GMP 
synthesis. Furthermore, two classes of c-di-GMP phosphodiesterases were identified. 
While HD-GYP domain proteins hydrolyze c-di-GMP directly to two molecules of GMP, 
EAL domain enzymes generate the linear product pGpG. Moreover, hybrid proteins 
comprising GGDEF as well as EAL or HD-GYP domains occur. These proteins either 
have both synthase and hydrolase activity or only one function, whereby the second 
domain is inactive and may fulfill a regulatory role. Numerous c-di-GMP receptors 
initiate downstream signaling responses. PilZ domain proteins for example induce 
reduced motility, transcription factors, different enzymes and riboswitches regulate 
processes such as biofilm matrix synthesis, surface adhesion, and virulence. Biofilm 
formation is often connected to a less virulent but antibiotic tolerant phenotype 
characteristic for chronic infections. Therefore c-di-GMP pathways are also interesting 
targets for antimicrobial therapies (reviewed in [11] and [12]). 
2.1.4 CYCLIC GMP 
For a long time cyclic GMP (cGMP, Figure 6) was 
thought to be only a by-product of cAMP synthesis and its 
potential function in bacteria was unknown. However, in 
2000 the specific cGMP synthase Cya2, which is 
homologous to class III adenylate cyclases, was identified 
in the cyanobacterium Synechocystis [13]. Aside from 
cAMP phosphodiesterases, which are also active towards Figure 6: Cyclic GMP 
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Figure 7: Cyclic GMP-AMP 
cGMP, evidence for a specific cGMP phosphodiesterase was also found in Synechocystis 
[14]. Moreover, it was shown that cGMP is essential for Rhodospirillum centenum to 
change between different developmental states [15] and the plant pathogen 
Xanthomonas campestris depends on cGMP for virulence and biofilm formation [16]. 
Still, the function of cGMP in bacteria is poorly understood. 
2.1.5 CYCLIC GMP-AMP 
Cyclic 3′-5′GMP-AMP (cGAMP, 
Figure 7) was only recently identified in 
Vibrio cholerae, but homologs of the cGAMP 
synthase DncV were subsequently found in 
other pathogenic bacteria such as E. coli 
and Acinetobacter baumannii. Interestingly, 
DncV adapts a similar fold as eukaryotic 
nucleotidyl transferases, such as the 2′-
5′cGAMP synthase cGAS. DncV is not 
essential; however, it is important for 
bacterial virulence: cGAMP stimulates 
intestinal colonization of V. cholerae and at 
the same time downregulates chemotaxis, resulting in a phenotype associated with 
hyperinfectivity [17]. It was shown that DncV is inhibited by folic acid, the biological 
role of this regulation is however not understood [18]. Finally, three cGAMP 
phosphodiesterases were identified in V. cholerae producing first pApG and in a 
second step ApG [19]. Nevertheless, the precise function of cGAMP in bacteria living in 
an abiotic environment as well as in their host remains to be investigated. 
2.2 THE DISCOVERY OF C-DI-AMP 
In 2006, Bejerano-Sagie et al. characterized the B. subtilis protein YacK in the 
context of a study on proteins involved in sporulation. The authors found that a 
knockout of YacK had no effect on cell division, sporulation, competence or on the 
response to DNA damage. However, upon treatment with the DNA damaging agents 
nalidixic acid and mitomycin C a YacK knockout strain produced more spores in total, 
but less viable spores. Based on these findings the authors concluded that YacK 
participates in a DNA damage checkpoint prior to sporulation and delays checkpoint 
activation in case of DNA damage. Furthermore it was found that YacK forms a single 
focus in the cell, co-localized with DNA. This globular focus moves rapidly in the cell 
until it binds to the site of DNA damage, where it stalls. Accordingly, YacK was 
renamed DisA (DNA integrity scanning protein A) [20]. 
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Two years later, Witte et al. analyzed the DisA protein in detail in a combined 
structural and biochemical approach. The crystal structure of DisA from Thermotoga 
maritima comprises an N-terminal globular α/β domain of unknown function 
connected to a helix-hairpin-helix (HhH) domain via a bundle of three α-helices. DisA 
from B. subtilis as well as from T. maritima was found to form a homo-octamer with 
two tetrameric rings assembled head-to-head, whereby the domains of unknown 
function face each other (Figure 8).  
 
Surprisingly, in the interface between two domains of unknown function an 
additional electron density was found. Its shape, interacting amino acids and above all 
mass spectrometry analysis proved this density to belong to cyclic di-AMP (c-di-AMP, 
Figure 9). Since no nucleotide was added during purification or crystallization of DisA, 
c-di-AMP had to be co-purified from E. coli or synthesized by DisA. Activity assays 
proved that DisA specifically produces c-di-AMP from ATP and that the domain of 
unknown function has diadenylate cyclase (DAC) activity. This was the first 
description of c-di-AMP and the DAC domain is still the only identified domain 
specifically producing c-di-AMP. 
Figure 8: T. maritima DisA. Top: Two DisA monomers as present in the asymmetric 
unit of the crystal (coloring according to domains: HhH domain grey, helical linker 
green, DAC domain blue). Bottom: Octameric assembly of DisA (PDB 3c1y [21]) 
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Figure 9: Cyclic di-AMP 
Additionally, it was shown that DisA 
binds to branched DNA structures such as 3′ 
and 5′ single-strand flaps and above all three-
way and four-way junctions, rather than 
single- and double-stranded DNA. Moreover, 
DisA not just binds to these DNA structures 
but is also inhibited in its DAC activity upon 
binding [21]. These findings indicate that DisA 
binds to recombination intermediates or 
stalled replication forks and signals this DNA 
damage by decreased c-di-AMP production. 
Consequently sporulation is delayed until the 
DNA is repaired and viable spores can be 
produced. However, the exact mechanism that leads to sporulation delay is still 
unknown. 
2.3 DIADENYLATE CYCLASES 
Different proteins comprising a DAC domain were identified bioinformatically 
in numerous bacteria since its discovery. DAC domain proteins are mainly found in 
Gram-positive bacteria of the phyla Firmicutes and Actinobacteria, but also in Gram-
negative Bacteroidetes, Cyanobacteria, Chlamydiae, Fusobacteria and 
Deltaproteobacteria and even in archaea of the phylum Euryarchaeota [22]. To date 
different DAC domain proteins from several bacterial species have also been  
experimentally proven to produce c-di-AMP; many of these bacteria are well known 
pathogens (Listeria monocytogenes [23], Staphylococcus aureus [24], Streptococcus 
pyogenes [25], Mycobacterium tuberculosis [26], Streptococcus pneumoniae [27], 
Bacillus thuringiensis [28], Mycobacterium smegmatis [29] and Borrelia burgdorferi 
[30]). 
Aside from DisA, two more major classes of DAC domain containing proteins 
occur. Homologs of B. subtilis YbbP (renamed DacA (diadenylyl cyclase A) [22] or 
CdaA (c-di-AMP synthase A) [31]) are the most abundant DAC domain proteins, 
representing 69% of all DACs. YojJ (renamed DacB (diadenylyl cyclase B) or CdaS (c-
di-AMP synthase sporulation specific)) proteins represent 6% of all DAC proteins, 
while 24% are homologs of DisA [22]. The DAC domains from DacA and DacB are very 
similar (40% sequence identity), while the one from DisA shows larger sequence 
variability (19% sequence identity compared to DacA or DacB) [32]. Most bacteria 
have only a single DAC, whereas for example B. subtilis possesses three different ones 
(DisA, DacA and DacB). 
DacA comprises three N-terminal transmembrane helices and a C-terminal 
DAC domain with relatively weak basal activity. However, YbbR from B. subtilis 
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(renamed CdaR, c-di-AMP synthase A regulator) was identified to be an interaction 
partner of DacA specifically activating its enzymatic activity more than 20-fold [31]. 
The regulation of CdaR and the mode of its interaction with DacA are however not 
understood. The expression level of DacA is higher during late exponential and 
stationary growth phase of S. aureus compared to early exponential phase, resulting in 
an increase of the intracellular c-di-AMP concentration from approximately 2.4 to 8.1 
µM [33]. Still, the function of increased c-di-AMP levels in later growth-phases 
remains to be elucidated. It was suggested that DacA or its DAC activity is involved in 
the control of cell wall metabolism, but how precisely this regulation might work and 
how the cell distinguishes between c-di-AMP produced by DacA and the other DAC 
domain proteins is still unknown. After T. maritima DisA, DacA from L. monocytogenes 
is only the second biochemically characterized DAC which’s crystal structure was 
solved [34]. The crystallized construct lacking the N-terminal transmembrane helices 
has the same fold as the DAC domain from T. maritima DisA and only the loop regions 
differ slightly (Figure 10 A), indicating a highly conserved structure and mechanism of 
DAC domains, which will be explained in detail in chapter 2.4. 
 
DacB is found exclusively in bacteria of the order Bacillales [22] and is 
expressed only during sporulation [35]. Consistently, knockout of DacB in B. subtilis 
results in a decrease in germination efficiency [36], the affected pathways are 
however unknown. DacB comprises a YojJ domain formed by two α-helices N-terminal 
of the DAC domain. The DacB homolog from Bacillus cereus was crystallized, however, 
Figure 10: (A) DAC domain of L. monocytogenes DacA in complex with ATP and Mg2+ (purple, 
PDB 4rv7 [34]) in superposition with the DAC domain from T. maritima DisA in complex with 
3′-dATP and Mn2+ (blue, PDB 4yvz [40]); rmsd 1.25 Å. (B) B. cereus BC_4920 (purple, PDB 2fb5 
[37]) in superposition with the DAC domain of T. maritima DisA (blue); rmsd 1.81 Å. 
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the protein was not biochemically characterized [37]. Still, the typical DAC fold is also 
conserved in this protein (Figure 10 B). Point-mutations in the α-helical YojJ domain 
of B. subtilis DacB, as well as deletion of this domain, lead to strongly increased DAC 
activity, indicating a regulatory function. Due to the crystal packing of the B. cereus 
DacB homolog, it was suggested that the protein oligomerizes via its YojJ domain also 
in solution in a manner that prevents the DAC domains from forming functional 
dimers [31,36]. However, the biological role of this regulation and how the 
autoinhibitory effect of the YojJ domain is overcome in vivo remains to be shown. 
DisA is the most active DAC of the three present in B. subtilis (DisA 79187 ng c-
di-AMP/mg protein; DacA + CdaR 5256 ng c-di-AMP/mg protein; DacB 562 ng c-di-
AMP/mg protein) [31], and is at the same time the most abundant DAC (DisA 179-465 
proteins/cell; CdaA 60-239 proteins/cell; CdaS expressed only during sporulation) 
[38]. It was shown that the expression level of DisA is higher during sporulation.  This 
allows screening for DNA damage not only prior to sporulation, but also before 
germination and outgrowth of the spores and to stall these processes in case of DNA 
damage [39]. Two different mechanisms of DisA regulation were identified so far. 
Firstly, the inactivation of DisA upon binding to branched DNA structures, as 
described in chapter 2.2; secondly, DisA is inactivated by interaction with RadA 
(radiation-sensitive gene A) [29]. The AAA+ ATPase RadA was found to interact with 
DisA in M. smegmatis, leading to inhibition of the DAC activity. Overexpression of DisA 
results in reduced motility and growth rate in M. smegmatis, which can be overcome 
by co-expression of RadA – indicating that the in vitro findings are of biological 
relevance [29]. Still, it is unknown how DisA and RadA interact in a manner 
inactivating DisA and upon which stimulus RadA binds to DisA. 
2.4 SYNTHESIS OF C-DI-AMP 
C-di-AMP is synthesized from two ATP molecules, which are cyclized by two 
3′-5′ linkages (Figure 9, page 17). Structural and biochemical studies revealed how the 
substrate ATP is coordinated in the active sites of DisA and DacA, respectively, and 
which conserved amino acids are essential for the reaction to take place. As shown in 
Figure 10 (page 18), the DAC domains from T. maritima DisA and L. monocytogenes 
DacA are very similar and also the bound nucleotides superimpose well, indicating a 
common structure and mechanism for all DAC domain proteins. 
DAC domains need to dimerize face-to-face in order to form a functional active 
site, positioning two ATP molecules in the correct orientation for the cyclization to 
take place. DisA forms a stable octamer in solution, as well as in the crystal structure, 
with the DAC domains in the center forming four active sites per octamer (Figure 8, 
page 16) [21,40]. Figure 11 illustrates how two molecules 3′-deoxy ATP (3′-dATP) are 
bound in the active site of T. maritima DisA. The two nucleotides are in ideal 
orientation for the nucleophilic attack from the 3′ hydroxyl group to the α-phosphate 
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to take place, while pyrophosphate is released [40]. 
The DAC domain of L. monocytogenes DacA was 
crystallized with its native substrate ATP, since the 
crystal packing does not allow formation of 
functional DAC dimers [34]. Still, the overall 
structure and position of the nucleotide are very 
similar, as mentioned before.  
Several highly conserved amino acids in the 
DAC domain, such as the DGA- and RHR-motifs, are 
essential for the reaction to take place. These 
residues were shown to interact with the 
nucleotides and/or the catalytically essential 
divalent metal ion [21,34,40,41]. The ion is 
octahedrally coordinated by Asp 75 belonging to the 
DGA-motif of the neighboring monomer, the 
nucleotide’s three phosphate groups, which are 
wrapped around it, and two water molecules 
(Figure 11) [40]. DisA from B. subtilis, T. maritima and B. thuringiensis was shown to 
be active in presence of Mg2+ [21,28], while M. tuberculosis DisA prefers Mn2+ over 
Mg2+ [26]. In contrast, L. monocytogenes CdaA is inactive in presence of Mg2+ and 
prefers Co2+ over Mn2+ [34]. It is still unknown why these very similar DAC domains 
favor different metal ions. 
Two studies with M. tuberculosis DisA indicate that the nucleophilic attacks 
from the 3′ hydroxyl groups to the α-phosphates do not take place simultaneously but 
rather in a sequential manner and that side-products of the reaction might occur. 
Analysis of an in vitro DAC reaction mixture by liquid chromatography revealed 
additional compounds next to ATP and c-di-AMP, which might be AMP, ADP and pApA 
[26] or pppApA [42]. Nevertheless, the dominant reaction taking place is still the 
formation of c-di-AMP from ATP. 
After its synthesis, c-di-AMP is tightly bound in the active site of DisA, as 
shown already in the first crystal structure where c-di-AMP was present, even though 
no nucleotide was added during purification or crystallization [21]. This strong 
binding of c-di-AMP results from the high number of coordinating residues and from 
the difficult exit through the narrow tunnel connecting the active sites in the center of 
DisA to the surface of the protein. It seems like the accessibility of the active site, 
rather than the reaction itself, is the rate limiting step in c-di-AMP synthesis of DisA 
[40]. So far DisA is the only DAC protein crystallized in an active conformation, 
therefore the mechanistic details and the way c-di-AMP is released from other DACs 
might differ. 
Figure 11: Close-up of one active site 
of T. maritima DisA (two monomers 
in light and dark blue) bound to 3′-
dATP, Mn2+ (purple) and selected 
waters (red); PDB 4yvz [40] 
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The di-nucleotidyl cyclase reactions catalyzed by DAC domain proteins, 
diguanylate cyclases, DncV and also eukaryotic cGAS produce very similar molecules. 
Still, the DAC domain shares neither its sequence nor fold or reaction mechanisms 
with the other enzymes. Similar to DACs, DGCs dimerize, whereby the active site is 
formed at the interface of both monomers. C-di-GMP is then synthesized in a two-step 
reaction via the reaction intermediate pppGpG, whereby the conserved GGDEF motif 
is involved in binding of GTP as well as Mg2+ or Mn2+ ions essential for the reaction to 
take place. Like DisA, also DGCs are rather static during the reaction cycle (reviewed 
in [12]). Nevertheless, no homology in sequence or structure can be observed 
between these enzymatic classes. 
Even though DncV and cGAS share only low sequence homology, both adapt a 
very similar nucleotidyl transferase fold. In contrast to DAC and DGC enzymes, both 
DncV and cGAS are active as monomers and bind ATP and GTP simultaneously in their 
active sites, performing the cyclase reaction by a two-step mechanism. However, DncV 
selectively generates 3′-5′-linked cGAMP through the reaction intermediate pppApG 
[43], while activated cGAS synthesizes a hybrid 2′-5′,3′-5′-linked molecule via the 
intermediate pppG(2′-5′)pA [44,45]. This linear reaction intermediate presumably 
exits the active site and rebinds in reversed orientation for the second 3′-5′-linkage to 
be formed [46]. Obviously, the reaction mechanisms as well as the fold of the proteins 
differ strongly between DACs and DncV/cGAS. 
2.5 C-DI-AMP SIGNALING PATHWAYS 
Next to its role in DNA damage signaling and sporulation, c-di-AMP was 
identified to also play a role in various other signaling pathways. Several receptors for 
c-di-AMP sensing and downstream signal transduction were found in different 
bacterial species and will be described in the following chapters. 
2.5.1 TRANSCRIPTION FACTOR DARR 
The first c-di-AMP receptor was identified in M. smegmatis in an assay testing 
predicted transcription regulators for their ability to bind radioactively labeled c-di-
AMP [47]. The protein DarR (c-di-AMP receptor regulator) comprises an N-terminal 
DNA-binding HTH domain and a C-terminal QacR-like receptor domain. DarR was 
found to specifically bind c-di-AMP with a moderate affinity of Kd = 2.3 µM. Moreover, 
binding of c-di-AMP increases the affinity of DarR towards its target DNA – a 
palindromic motif formed by two inverted repeats. Additional DNA binding 
experiments and analysis of the genome of M. smegmatis proved that DarR binds not 
only to its own promotor, but regulates also the expression of a predicted cold-shock 
protein, an uncharacterized major facilitator family transporter and a medium chain 
fatty acyl-CoA ligase. However, DarR is not essential; its knockout only results in an 
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increased cell length, consistent with c-di-AMP influencing cell wall and membrane 
metabolism. In contrast, strong overexpression of DarR is toxic for M. smegmatis. 
Comparison of the expression levels of DarR target genes in knockout and mildly 
overexpressed strains revealed that DarR is a negative regulator of its targets. These 
results indicate that c-di-AMP signaling is involved in the response to environmental 
stress, fatty acid metabolism and therefore cell membrane homeostasis, and transport. 
So far only DarR from M. smegmatis was analyzed and shown to act c-di-AMP 
dependently, however, several conserved homologs of this protein exist in other 
bacterial species (mycobacteria, Corynebacterium variabile and Rhodococcus 
erythropolis). Therefore DarR might not be specific to M. smegmatis, but seems not to 
be a universal c-di-AMP receptor as well [47]. 
2.5.2 POTASSIUM HOMEOSTASIS 
Potassium (K+) is not only an essential, but also the most abundant cation in 
cells and its import is crucial due to limited availability. K+ is important for the activity 
of different enzymes, osmoregulation, cell volume control and pH homeostasis 
(reviewed e.g. in [48]). Several proteins involved in K+ import were found to be c-di-
AMP receptors. Corrigan et al. performed pull-downs with c-di-AMP coupled beads 
from S. aureus cell lysate and thereby identified three proteins associated to ion 
transport: KtrA, the cytosolic regulatory part of the KtrAB K+ transporter, KdpD, a 
sensor histidine kinase controlling the expression of K+ uptake systems and virulence 
factors, and CpaA, a cation/proton antiporter [49]. 
KtrB is a K+ channel belonging to the superfamily of K+ transporters present in 
bacteria, archaea, fungi and plants. It forms a stable dimer in the cell membrane, 
whereby each monomer comprises one K+ channel in its center. KtrA is a cytosolic 
protein able to bind to KtrB and thereby modulates its activity. It comprises an N-
terminal ATP/ADP/NADH binding domain with a Rossman fold and a less conserved 
C-terminal domain (reviewed e.g. in [50]). KtrA forms an octamer, whereby four 
dimers are assembled in a ring, interacting with KtrB via the N-terminal domains 
(Figure 12 A). While KtrB alone has weak ion transport activity, it is strongly 
increased when KtrA binds to the channel and even more, when KtrA is in complex 
with ATP instead of ADP. It was shown that the B. subtilis KtrA octamer adopts a 
square conformation when bound to ATP and a more oval ‘diamond’ conformation in 
complex with ADP due to rotation of the KtrA molecules relative to each other (Figure 
12 B). This change is then transduced by a not fully understood mechanism to one of 
the ion-gate regions of KtrB to activate or inactivate the channel [51]. Interestingly, c-
di-AMP does not bind to the N-terminal nucleotide binding domain of KtrA, but 
specifically to the C-terminal RCK_C domains of S. aureus and B. subtilis KtrA. 
Moreover, binding of c-di-AMP leads to inactivation of the channel [49]. Studies with 
KtrA from S. pneumoniae (also called CabP, c-di-AMP binding protein) revealed that 
KtrA in complex with c-di-AMP is not able to interact with KtrB and thereby leads to 
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closing of the channel, resulting in measurably reduced K+ import into the cell [52]. 
The crystal structure of the RCK_C domain of S. aureus KtrA with c-di-AMP bound in a 
pocket in the dimer interface was solved recently (Figure 12 C) [53]. However, since 
the structure lacks the N-terminal domain necessary for interaction with KtrB it is not 
possible to speculate on structural changes leading to dissociation of KtrA from KtrB. 
In summary, there exist different mechanisms of KtrAB regulation: activation of the 
channel by binding of ATP-KtrA, mild inactivation in the ADP-KtrA state and strong 
inactivation upon dissociation of c-di-AMP-KtrA. However, it is unknown if ATP/ADP 
and c-di-AMP bind to KtrA simultaneously or even in a cooperative manner and what 
the effect on the KtrB activity state is. Nevertheless, KtrA is clearly important for 
bacteria to regulate K+ uptake, as knockout strains are severely inhibited in growth 
and are more sensitive to hyperosmotic conditions and antibiotics [54]. 
Aside from KtrA, an additional protein containing an RCK_C domain was 
identified in S. aureus. CpaA (cation/proton antiporter) comprises an N-terminal 
transmembrane region and a C-terminal RCK_C domain shown to bind to c-di-AMP 
[49]. CpaA was found to act as an H+/Na+ and H+/K+ antiporter without any preference 
for Na+ or K+ being imported into the cell. In contrast to KtrAB, binding of c-di-AMP to 
Figure 12: (A) KtrAB from B. subtilis. The channel KtrB (light and dark grey) with K+ inside depicted as 
orange sphere, the KtrA octamer is coloured in green, blue, purple and red (PDB 4j7c [51]). (B) B. subtilis 
KtrA dimer in ATP (blue) and ADP (purple) bound state (PDB 4j90 and 4j91, respectively [51]). (C) 
RCK_C domain dimer of S. aureus KtrA (light and dark blue) in complex with c-di-AMP (PDB 4xtt [53]). 
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the RCK_C domain of CpaA activates the transporter and results in increased ion 
transport. The crystal structure of CpaA lacking the transmembrane region was solved 
in complex with c-di-AMP. The overall fold of the crystallized construct is very similar 
to KtrA and also c-di-AMP is bound in a similar way. Still, the interaction of RCK_C 
with the transmembrane region remains obscure and it is therefore unknown how c-
di-AMP facilitates activation of the transporter [55].  
The third ion-homeostasis related c-di-AMP receptor identified in S. aureus is 
the membrane bound sensor histidine kinase KdpD [49]. The KdpD/KdpE system is 
widely spread among many different bacterial species, also those deficient of c-di-
AMP. When bacteria lack K+ or live in high osmolarity conditions, KdpD 
autophosphorylates and thereupon phosphorylates KdpE, which in turn activates 
transcription of the K+ uptake system KpdFABC (reviewed e.g. in [56]). However, it 
was shown that the KdpD system has an additional function in S. aureus: next to K+ 
transporters, KdpD/KdpE also controls the expression of virulence factors in 
dependence on the K+ concentration [57]. The specific c-di-AMP binding activity was 
assigned to a conserved motif in the N-terminal USP domain of KdpD. Furthermore, c-
di-AMP binding negatively regulates the expression of the K+ transport protein KdpA 
[58]. To date, there is no structural information available on how c-di-AMP binding 
affects KdpD and how exactly KdpA expression is inhibited. Moreover, the biological 
function of three different K+ importers being regulated oppositely, KtrAB and KdpD 
being inactivated by c-di-AMP and CpaA being inactivated, remains to be investigated. 
2.5.3 PSTA 
PstA (PII-like signal transduction protein A) was identified to bind c-di-AMP in 
S. aureus [49]. PII proteins are a class of proteins omnipresent in bacteria, archaea and 
plants and are often involved in the regulation of nitrogen metabolism. They are able 
to sense ligands such as 2-oxoglutarate and/or adenosine nucleotides and initiate 
subsequent downstream signaling by interaction with transcription factors, 
transporters and different enzymes. PII proteins share a compact trimeric head 
domain with a conserved ferredoxin-like fold and large protruding loops for 
interaction with their target proteins (reviewed e.g. in [59]). PstA from S. aureus, L. 
monocytogenes and B. subtilis (also called DarA, c-di-AMP receptor A) was analyzed in 
detail concerning its structural features and c-di-AMP binding characteristics [60–63]. 
PstA is also trimeric with the typical ferredoxin-like fold (Figure 13 A), but differs 
from canonical PII proteins regarding the protruding loops, which are swapped in 
length: the T-loop, which usually comprises approximately 20 amino acids and 
interacts with target proteins, has only 8 residues, whereas the B-loop has a length of 
33 amino acids in PstA compared to approximately 8 residues in PII proteins. PstA 
selectively binds c-di-AMP with very high affinity (KD = 109 – 370 nM; ka = 6.4 ∙ 105 M-
1s-1; kd = 0.07 – 0.08 s-1; numbers from [60] and [61] respectively) and binds only 
weakly to 3′5′-cGAMP [62]. The crystal structure shows that c-di-AMP is bound in a 
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positively charged pocket between two subunits (Figure 13 B). The short T-loop, 
which is flexible in the nucleotide free structure, bends towards the outer adenine 
moiety, while the inner is deeply buried and specifically recognized by a backbone 
interaction with N6 (Figure 13 C). However, the large B-loop is flexible and therefore 
unresolved in the crystal structure. Still, there is some evidence, that the loop might 
become more structured upon binding of c-di-AMP. It is unknown whether the 
movement of the T-loop towards c-di-AMP observable in the crystal structure serves 
as the downstream signal, or if the large B-loop indeed undergoes structural changes 
initiating a response. Unfortunately, no interaction partners of PstA were identified so 
far, and therefore speculation on structural changes of PstA facilitating interaction 
with target proteins is not possible. It was shown that PstA is not essential in B. 
subtilis [62] and that knockouts show no phenotype in L. monocytogenes [63]. 
However, many bacteria producing c-di-AMP possess PstA [61], therefore this 
receptor is not universal, but probably still important.  The signaling pathway 
modulated by PstA still needs to be discovered to understand the structural findings 
in its context. 
Figure 13: (A) Trimeric assembly of S. aureus PstA in complex with c-di-AMP. (B) Electrostatic surface 
representation (red: negative charge, blue: positive); c-di-AMP is buried in a positively charged pocket 
between two subunits. (C) Close up of c-di-AMP in its binding pocket (PDB 4wk1 [60]). 
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2.5.4 YDAO RIBOSWITCH 
In addition to the protein receptors described before, the Ydao riboswitch 
class was identified to specifically recognize c-di-AMP and to regulate gene expression 
dependent on the second messenger’s binding. The YdaO riboswitch class is one of the 
most common and is present in numerous bacterial species. It is associated with genes 
involved for example in cell wall metabolism, osmotic stress and sporulation. 
Moreover, it was shown that the riboswitch specifically binds c-di-AMP with very high 
affinity (KD ≤ 0.7 nM) and acts as a negative regulator of gene expression [64]. The c-
di-AMP sensing domains of the YdaO riboswitches from Thermoanaerobacter 
tengcongensis, Thermoanaerobacter pseudethanolicus and Thermovirga lienii were 
crystallized in complex with c-di-AMP, elucidating the details of ligand binding 
[65,66]. YdaO forms a square-shaped pseudosymmetrical structure comprising five 
helices, a pseudoknot and long range tertiary pairs (Figure 14). Unexpectedly, the 
riboswitch showed to bind two molecules of c-di-AMP in pseudo two-fold symmetric 
manner in binding pockets in opposite corners of the square shaped RNA. Upon 
formation of the structure characteristic for the c-di-AMP bound state, the 3′ 
expression platform of the riboswitch is able to form a transcription terminator and 
thereby switches off transcription. In contrast, when YdaO is in its ligand-free state 
the stem P1 (green in Figure 14) is not formed leading to alternate base pairing, which 
disrupts the terminator structure [65,66]. Numerous genes are regulated via this 
mechanism and the YdaO riboswitch class is clearly an important and widely spread c-
di-AMP receptor. 
 
 
 
Figure 14: (A) Secondary structure of the T. tengcongensis YdaO riboswitch as observed in the crystal 
structure (c-di-AMP binding regions highlighted in yellow). (B) Crystal-structure of the riboswitch in 
complex with c-di-AMP (color code as in A, c-di-AMP grey) (PDB 4qln [65]). Figure adapted from [65]. 
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2.5.5 PYRUVATE CARBOXYLASE 
The most recently identified c-di-AMP receptor is the PC (pyruvate 
carboxylase), shown to bind c-di-AMP in L. monocytogenes [67]. The PC is a central 
metabolic enzyme synthesizing oxaloacetate, a precursor e.g. for amino acid 
biosynthesis, from pyruvate. Due to its central function, the PC is essential for growth 
of L. monocytogenes intra-, as well as extracellularly [68]. The PC forms a homo-
tetramer and comprises four domains per polypeptide chain: the N-terminal biotin 
carboxylase (BC) domain, the carboxyltransferase (CT) domain, an allosteric or 
tetramerization (PT) domain and the C-terminal biotin carboxyl carrier protein 
(BCCP) domain. During the reaction cycle, covalently bound biotin is first carboxylated 
in the BC active site by ATP and bicarbonate; then the carboxy group is transferred 
from biotin to pyruvate in the active site of the CT domain to generate oxaloacetate. To 
facilitate this two-step reaction, the BCCP domain transfers biotin between the two 
distinct active sites of the BC and CT domains. It was shown that the PC of different 
species is allosterically activated by acetyl-CoA. Acetyl-CoA binds to the PT domain 
and activates the PC by decreasing the distance between neighboring active sites [69]. 
In contrast, c-di-AMP was found to inhibit the L. monocytogenes PC allosterically (Ki = 
3 µM) [67]. The crystal structure of PC in complex with c-di-AMP revealed that c-di-
AMP is bound at the dimer interface of two CT domains, 25 Å away from the CT active 
sites (Figure 15 A). Comparison with the apo form of the enzyme shows major 
rearrangements of the domains upon ligand binding. In general, the four monomers in 
apo PC have larger variability in respect of their domain orientation and, more 
specifically, the position of the BC domains relative to the CT domains change upon 
binding of c-di-AMP (Figure 15 B). The PC needs to undergo large movements during 
the reaction cycle in order to carry biotin first to the active site of the BC and then to 
the CT domains, consistent with the less static apo structure. Presumably c-di-AMP 
locks the PC in a conformation incompatible with catalysis [67]. 
C-di-AMP was shown to reduce the rate of PC dependent amino acid 
biosynthesis in L. monocytogenes resulting in metabolic imbalance; the biological 
function of this regulatory mechanism is however not understood. Similarly, it is not 
clear how widely spread the c-di-AMP sensory function of the PC is. The c-di-AMP 
binding site is poorly conserved; still, it was shown that c-di-AMP inhibits not only the 
PC from L. monocytogenes, but also the one from Enterococcus faecalis; the PC from S. 
aureus however, is not responsive to c-di-AMP [67]. 
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2.5.6 CROSSTALK BETWEEN C-DI-AMP AND (P)PPGPP PATHWAYS 
A link between c-di-AMP pathways and the stringent response second 
messenger (p)ppGpp was identified, when the B. subtilis c-di-AMP phosphodiesterase 
GdpP was found to be inhibited by (p)ppGpp, resulting in increased intracellular c-di-
AMP concentrations (described in detail in chapter 2.6) [70]. More recently, c-di-AMP 
was found to interact also with (p)ppGpp pathways in S. aureus [33]. A GdpP knockout 
strain with strongly elevated c-di-AMP concentrations was analyzed. Interestingly, 
this strain exhibits a similar expression pattern as observed during stringent 
response, with genes e.g. for amino acid synthesis and transport being activated. 
Moreover, the intracellular concentration of (p)ppGpp is increased in a methicillin 
resistant strain and even more strongly elevated in methicillin sensitive S. aureus. This 
increase in (p)ppGpp was assigned to the bi-functional (p)ppGpp synthase and 
hydrolase RSH (also known as RelA). However, the transcription of RSH is not 
elevated in the GdpP knockout strain and no direct interaction of RSH with c-di-AMP 
was observed [33]. Therefore the mechanism of c-di-AMP dependent RSH activation is 
still unknown. In summary, c-di-AMP indirectly activates RSH, which produces more 
(p)ppGpp. (p)ppGpp in turn inhibits GdpP, leading to increased c-di-AMP levels, 
activating the RSH even more. However, it is unknown so far how this positive 
Figure 15: (A) L. monocytogenes pyruvate carboxylase bound to c-di-AMP (red) in tetrameric assembly 
(biotin carboxylase domains blue, carboxyltransferase domains purple, tetramerization domains green, 
biotin carboxyl carrier protein domains yellow; PDB 4qsh). (B) Superposition of a PC monomer (CT, PT 
and BC domains shown) in c-di-AMP bound (blue) and apo form (purple) (PDBs 4qsh and 4qsl, 
respectively [67]). 
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feedback regulation is stopped and its biological function is also not understood in 
detail. 
Another study describes a very different interplay between c-di-AMP and 
(p)ppGpp. L. monocytogenes expresses only a single DAC protein, DacA, which is 
essential. However, ΔDacA L. monocytogenes strains could be obtained after 
suppressor mutations were introduced in bacteria grown in macrophages [71]. 94% 
of these mutations occurred in the oppABCDF operon encoding the oligopeptide 
permease Opp that lost its function due to the mutations. 2% were loss of function 
point-mutations in the synthase domain of the bi-functional (p)ppGpp 
synthase/hydrolase RelA. RelA synthesizes (p)ppGpp in response to starvation and is 
at the same time the only (p)ppGpp hydrolase present in L. monocytogenes, while two 
additional synthases (RelP and RelQ) with low basal activity exist. Despite a weak 
growth defect, knockout of RelA as well as of all three (p)ppGpp synthases (ΔRelAPQ) 
made DacA dispensable. In contrast, a conditional depletion of DacA in wild type L. 
monocytogenes resulted in strongly increased (p)ppGpp levels also under non-
starvation conditions and a severe growth defect. This led to the conclusion that DacA 
is essential due to toxic accumulation of (p)ppGpp in its absence. Interestingly, the 
ΔRelAPQ strain not dependent on DacA exhibited reduced virulence.  The link 
between virulence and (p)ppGpp levels was searched via suppressor mutations. The 
mutant strain most similar to wild type bacteria harbored a loss of function mutation 
in the negative transcription regulator CodY [71]. It was shown already before that 
when L. monocytogenes comprises high intracellular levels of (p)ppGpp, GTP synthesis 
is strongly inhibited. However, GTP is a cofactor of CodY, which becomes inactive 
when it is not bound to this nucleotide. Consequently, inactive CodY does not repress 
transcription of its target genes anymore. Among the numerous genes usually 
repressed by CodY are for example those needed for adaptation to lack of nutrients, 
but in B. subtilis also the oppABCDF operon (reviewed in [72]). Consistently, knockout 
of CodY leads to constitutive expression of the genes usually repressed. Surprisingly, 
in the ΔRelAPQΔCodY mutant strain DacA was found to be essential, implying that 
genes expressed in absence of CodY are toxic in the absence of c-di-AMP [71]. To 
summarize, in L. monocytogenes c-di-AMP reduces (p)ppGpp levels via an unknown 
mechanisms. These low (p)ppGpp concentrations lead to indirect activation of the 
negative transcription regulator CodY, which represses transcription of genes which 
are toxic in absence of c-di-AMP. It is however not known which gene products might 
be toxic in cells lacking c-di-AMP. 
In contradiction to the finding that c-di-AMP reduces the concentration of 
(p)ppGpp described by [71], another study showed that L. monocytogenes lacking its 
c-di-AMP PDE PgpH has increased levels of (p)ppGpp due to accumulation of c-di-AMP 
[73]. This is consistent with the findings in S. aureus that c-di-AMP and (p)ppGpp 
regulate each other positively [33]. The interplay between c-di-AMP and (p)ppGpp 
clearly needs to be studied in more detail to properly evaluate the previously 
described findings. 
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2.6 C-DI-AMP DEGRADATION 
Controlled degradation of c-di-AMP is as important as the regulation of its 
synthesis. Three different types of c-di-AMP specific phosphodiesterases (PDE) have 
been identified in several bacterial species: Homologs of B. subtilis GdpP (GGDEF 
domain protein containing phosphodiesterase, formerly YybT; PdeI in S. pneumoniae, 
PdeA in L. monocytogenes) comprise N-terminal trans-membrane helices, a regulatory 
PAS domain, a degenerated GGDEF domain and C-terminal DHH/DHHA1 domains for 
c-di-AMP hydrolysis  [24,27,70,74,75]. In addition, a shorter version of this protein 
lacking the N-terminal domains is present in several bacterial species [27,30,76,77]. 
The third type of c-di-AMP PDE identified in L. monocytogenes comprises an 
extracellular 7TMR-HDED domain, a transmembrane region and the intracellular c-di-
AMP hydrolyzing HD domain [78] (Figure 17). 
 
Figure 17: Domain organization of different c-di-AMP phosphodiesterases (TM = transmembrane helices).  
Figure 16: Overview on the crosstalk between c-di-AMP and (p)ppGpp 
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B. subtilis GdpP was the first c-di-AMP PDE identified [70]. The c-di-AMP 
degrading activity was assigned to the C-terminal DHH/DHHA1 domains that 
hydrolyze c-di-AMP, and less efficiently also c-di-GMP, exclusively to the linear 
product 5′-pApA. The enzymatic activity is dependent on Mn2+ and several conserved 
amino acids presumably involved in its coordination [24,70]. The N-terminal 
transmembrane helices anchor the protein to the cell-membrane. The correct 
localization of GdpP seems to be important for its function, as was shown in S. 
pyogenes [75]. The GGDEF domain C-terminal to the DHH/DHHA1 domains is usually 
associated with c-di-GMP synthesis. However, in GdpP this domain is highly modified 
compared to canonical GGDEF proteins and lacks the characteristic amino acid motif. 
It was shown that the GGDEF domain of B. subtilis GdpP has weak ATPase activity; it is 
however unknown what the biological significance of this activity might be [70].  
The small N-terminal PAS (Per-ARNT-Sim) domain was shown to regulate c-
di-AMP hydrolysis. PAS domains in general are known to be redox, oxygen or carbon 
monoxide (CO) sensors in different proteins. The PAS domains from Geobacillus 
thermodenitrificans and B. subtilis GdpP were analyzed in detail regarding their ligand 
binding characteristics [79]. The purified protein was found to contain low amounts of 
type B heme and could be reconstituted to bind heme in a 1:1 stoichiometry. Heme 
bound GdpP was found to be less active than apo GdpP, indicating a regulatory 
function of heme. Moreover, GdpP in complex with Fe(II) heme is able to bind NO 
(nitric oxide), CO and CN- (cyanide), while oxidized Fe(III) heme only binds to CN-. NO, 
as well as CN-, weakly activate heme-GdpP in both, oxidized and reduced state. NO, 
being a reactive nitrogen species synthesized by the mammalian immune system in 
order to kill bacteria, likely represents the 
physiological ligand of heme-GdpP. Therefore the 
PAS domain of GdpP seems to function as a sensor 
for heme or NO, which might act as markers for 
the mammalian host environment [79]. The NMR 
structure of the PAS domain from G. 
thermodenitrificans GdpP was elucidated and 
revealed a hydrophobic pocket for heme binding 
(Figure 18) [80]. Heme was shown to be bound in 
a hexacoordinated state in the PAS domain, while 
Fe(II)-NO heme is pentacoordinated, implying 
that an amino acid dissociates from heme upon 
NO binding [70]. However, a suitable ligand, such 
as histidine or cysteine, was not identified so far 
and the exact mechanism of inactivation or 
activation of GdpP upon binding of Heme(-NO) is 
not understood. While B. subtilis GdpP lacking the 
PAS domain was shown to be less active than the 
full-length protein (full-length B. subtilis apo 
Figure 18: NMR structure of dimeric 
PAS domain of G. thermodenitrificans 
GdpP (PDB 2m1c [80]) 
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GdpP: kcat = 0.55 s-1, Km = 1.3 µM; holo-GdpP kcat = 0.024 s-1, Km = 16 µM; ΔPAS B. 
subtilis GdpP: kcat = 0.074 s-1, Km = 3 µM) [70,79], a study with the homologous S. 
pneumoniae Pde1 showed that a truncated version of the protein lacking the PAS 
domain has the same activity as the full-length enzyme [27]. Clearly, the PAS domain 
needs to be studied in context of the whole protein to fully understand the mechanism 
of PDE activity regulation. 
There is evidence, that the expression levels of B. subtilis GdpP are higher 
during sporulation and that GdpP expression depends on the presence of DisA [20]. 
However, another study shows that GdpP is constitutively expressed during the whole 
growth cycle of S. aureus [33]. There might be species specific differences in the 
expression pattern of GdpP, which need to be further analyzed to understand the 
biological function of its regulation. Surprisingly, the stringent response second 
messenger ppGpp was found to act as a competitive inhibitor of GdpP (B. subtilis: 
apparent IC50 = 234 µM, KI = 36 µM; S. aureus KI = 130 µM; intracellular ppGpp 
concentration > 1 mM). ppGpp is known to signal starvation in bacteria and 
presumably also leads to an increase in the c-di-AMP concentration by inhibition of its 
degradation [33,70]. Further details on the crosstalk between c-di-AMP and (p)ppGpp 
pathways were given already in chapter 2.5.6, page 28. 
After the DHH/DHHA1 domains were identified to hydrolyze c-di-AMP, 
proteins comprising only these domains and lacking the transmembrane helices and 
the GGDEF and PAS domains were found in different bacterial species. In contrast to 
GdpP, S. pneumoniae Pde2, M. tuberculosis CnpB or PDE and M. smegmatis PDE, which 
are all homologous despite their different names, specifically hydrolyze c-di-AMP and 
pApA to AMP. PDEs from this class are dimeric and, like GdpP, depend on Mn2+ 
[27,42,76,77]. Little is known about the mechanism of c-di-AMP or pApA hydrolysis. 
The conserved DHH and DxD motifs presumably coordinate Mn2+ and are therefore 
essential for catalysis. S. pneumoniae Pde2 was shown to prefer pApA over c-di-AMP 
(pApA Vmax = 334 nmol mg-1min-1; c-di-AMP Vmax = 49 nmol mg-1min-1). Nevertheless, 
knockouts of the GdpP homolog Pde1 and also Pde2 result in comparably decreased 
intracellular c-di-AMP levels in S. pneumoniae, therefore Pde2 also possesses c-di-AMP 
hydrolyzing activity in vivo [27]. Borrelia burgdorferi DhhP, the only characterized 
PDE from a Gram negative bacterium, comprises the same DHH/DHHA1 domain 
organization as the enzymes described previously. However, it was shown to produce 
pApA rather than AMP from c-di-AMP. Moreover, DhhP is essential in vivo as well as in 
vitro, unlike other PDEs investigated so far [30]. 
The third class of c-di-AMP PDEs contains only one characterized enzyme so 
far. L. monocytogenes PgpH comprises an extracellular 7TMR-HDED domain, seven 
transmembrane helices and an intracellular HD domain. The HD domain belongs to a 
superfamily containing also c-di-GMP PDEs; the HD domain from PgpH however was 
shown to strongly prefer c-di-AMP over c-di-GMP to synthesize the linear product 
pApA. Like the DHH/DHHA1 domain PDEs also PgpH depends on Mn2+, which is 
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Figure 19: HD domain of L. monocytogenes PgpH in complex with c-di-AMP and 
two Fe(II) ions shown as yellow spheres, HD motif as sticks (PDB 4s1b [78]) 
coordinated by the characteristic His-Asp motif (Figure 19). Interestingly, ppGpp was 
found to inhibit PgpH allosterically (IC50 = 200-400 µM), in contrast to GdpP, which is 
inhibited competitively [78]. However, the binding site of ppGpp and the way it 
inhibits the enzyme was not identified so far. L. monocytogenes possesses two c-di-
AMP PDEs: next to PgpH it has a GdpP homolog named PdeA providing a PAS-GGDEF-
DHH/DDHA1 domain architecture as described previously [74]. However, PgpH 
seems to be the major PDE, since a knockout of PgpH has a larger effect on the amount 
of c-di-AMP secreted by L. monocytogenes than a knockout of PdeA has [78]. Even 
though only one member of HD domain c-di-AMP PDEs was characterized so far, this 
class of PDEs seems to play an important role in c-di-AMP hydrolysis. Homologs of L. 
monocytogenes PgpH were identified in 36% of all DAC containing bacteria, among 
them also species shown to comprise also a DHH/DHHA1 PDE, for example B. subtilis 
[78]. 
 
2.7 THE IMPORTANCE OF C-DI-AMP IN BACTERIA 
Overexpression and knockouts of DACs and PDEs lead to increased or reduced 
cellular c-di-AMP levels with characteristic and severe phenotypes. Many of them are 
not understood in detail and cannot be assigned to specific pathways yet. Moreover, in 
all but one c-di-AMP synthesizing species, which were analysed so far, c-di-AMP was 
found to be essential. In B. subtilis double knockouts of DisA and DacA are not possible 
[31,81] and knockouts of the single DAC domain proteins in L. monocytogenes 
[23,71,74], S. pyogenes [25], S. pneumoniae [27] and S. aureus [33] showed to be lethal 
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as well. Therefore the effects of decreased c-di-AMP levels were investigated either by 
conditional depletion of DACs or by overexpression of PDEs, both resulting in similar 
phenotypes. As described already in chapter 2.2 (page 15), knockout of B. subtilis DisA 
results in production of non-viable spores upon introduction of DNA damage [20] and 
renders the cells more sensitive to DNA damaging agents [82]. These effects most 
likely represent DisA specific phenotypes and not a general result of the lack of c-di-
AMP. Concerning the overall cell characteristics, low c-di-AMP levels lead to slower 
bacterial growth in L. monocytogenes and S. aureus [33,74], while faster growth was 
observed in methicillin resistant S. aureus (MRSA), a phenotype usually associated 
with decreased antibiotic resistance in this species [83]. Similarly, less intracellular 
growth of L. monocytogenes was observed also in host cells [74]. Furthermore, 
decreased levels of c-di-AMP seem to have a destabilizing effect on the bacterial cell 
wall, as more cell lysis occurred in B. subtilis and L. monocytogenes [74,81], while S. 
aureus was shown to form incomplete septa [33] and M. smegmatis produces less 
fatty acids [77]. Consequently, bacteria lacking c-di-AMP are more susceptible 
towards cell wall targeting antibiotics such as β-lactams. This has been shown for B. 
subtilis, L. monocytogenes and MRSA [74,81,83,84]. M. tuberculosis is the only species 
identified so far, where c-di-AMP was found to be not essential. A knockout of its only 
DAC could be generated and the bacteria subsequently had a growth defect and a 
more virulent phenotype [76,85]. 
An increase in c-di-AMP levels by DAC over-expression or PDE knockout also 
leads to severe phenotypes. In B. subtilis an elevated c-di-AMP concentration results in 
rapid entry into sporulation [41] and more spores are produced after generation of 
DNA damage [70]. Additionally, several phenotypes regarding growth and 
morphology were described for different species after increasing the c-di-AMP 
concentration. B. subtilis [31], M. smegmatis [29], S. pneumoniae [27], S. aureus [33] 
and L. monocytogenes [78] have a slower growth rate upon increase in c-di-AMP 
concentrations and similarly M. tuberculosis [85] and L. monocytogenes [78] were 
shown to grow more slowly or not at all in host cells. Reduced cell size was observed 
in S. aureus [24], S. pneumoniae [27] and M. tuberculosis [76], while M. smegmatis 
[29,77] and B. burgdorferi [30] show elongated cells due to defective cell division. In 
addition, B. subtilis forms curled cell filaments [31] and M. smegmatis cells aggregate 
and are less motile [29,77]. Consistently, S. aureus produces more biofilms upon an 
increase in c-di-AMP levels [24]. The effect of high c-di-AMP concentration on the 
bacterial cell wall is complementary to the phenotypes observed in c-di-AMP depleted 
cells. High c-di-AMP levels lead to more cross-linked peptidoglycane in S. aureus and 
compensate for lipoteichoic acid depletion [24]. Furthermore, L. monocytogenes 
comprises a thicker cell wall [84] and increased acid resistance [74], which is also true 
for B. subtilis [70]. As a result of the more robust cell wall bacteria with high c-di-AMP 
levels are more resistant to cell wall antibiotics, as was shown for S. aureus [24,86], B. 
subtilis [81], S. pyogenes [75] and L. monocytogenes [74,84]. Nevertheless, an increase 
in c-di-AMP concentration leads to a less virulent phenotype in S. pyogenes [75], S. 
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pneumoniae [27], M. tuberculosis [76,85], B. burgdorferi [30] and L. monocytogenes 
[78]. There exists one exception to the phenotypes described before: B. burgdorferi, 
the only Gram negative species producing c-di-AMP characterized in detail so far, does 
not show increased resistance to antibiotics upon an increase in c-di-AMP levels and is 
the only species for which was shown that the PDE is essential [30]. 
The phenotypes observed after increase or decrease of c-di-AMP levels 
concern sporulation, cell growth and morphology, virulence and above all the cell wall 
and antibiotic resistance. Even though neither the cellular pathways modulated by c-
di-AMP to result in these phenotypes, nor the key mechanism making c-di-AMP 
essential are understood in detail, it is obvious that the intracellular concentration of 
c-di-AMP needs to be precisely regulated. This is why DAC inhibitors have been 
suggested as new antimicrobial drugs. Two compounds inhibiting DisA were 
investigated so far (Figure 20). Bromophenol thiohydantoin (bromophenol TH) was 
identified as a DisA inhibitor during the screening of a whole library of small 
molecules. The inhibitor presumably acts allosterically with an IC50 of approximatey 
100 µM [87]. The second inhibitor identified, 3′-dATP, is a competitive inhibitor of T. 
maritima DisA and likely also other DACs, since it is a non-reactive substrate analog 
binding in the active site of DisA (Figure 10 and Figure 11, pages 18-20). 3′-dATP 
inhibits DisA with an IC50 of 3 µM [40] and has previously been shown to inhibit 
growth of Clostridium species [88]. Since 3′-dATP is an ATP analog it probably affects 
many different enzymes, but DACs are certainly among them. Moreover, the pro-drug 
3′-deoxy adenosine, which is phosphorylated to 3′-dATP in the cell, is also tested in 
cancer therapy in clinical trials. 
 
 
 
Figure 20: The two DisA inhibitors identified so far, Bromophenol-TH [87] and 3′-dATP [40] 
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2.8 C-DI-AMP IN EUKARYOTES 
2.8.1 INTRACELLULAR BACTERIA 
L. monocytogenes and M. tuberculosis are intracellular pathogens able to 
replicate also in eukaryotic host cells. L. monocytogenes possesses multidrug efflux 
pumps (MDR) for export of small molecules, often prerequisite for antibiotic 
resistance. It was however shown that the bacterium also secretes c-di-AMP with the 
help of its MDRs into the cytosol of its host cell [23,89]. A clear correlation between 
the amount of produced and subsequently secreted c-di-AMP and the intensity of the 
host cell’s immune response, measured via the interferone-β (IFN-β) concentration, 
was observed. In particular, knockdown of DACs and therefore reduced c-di-AMP 
levels lead to less IFN-β production, while DAC overexpression or PDE knockout 
results in elevated IFN-β levels, compared to infections with wild type bacteria. It was 
shown that L. monocytogenes secrets c-di-AMP via its MDRs; it is however unknown 
how M. tuberculosis exports the nucleotide. Still, both species initiate enhanced IFN-β 
synthesis in response to increased levels of c-di-AMP. High induction of IFN-β 
expression is associated to a less virulent bacterial infection [74,76,78,85]. Similarly, 
less c-di-AMP leads to reduced IFN-β production and a more virulent phenotype of M. 
tuberculosis [76,85]; however, the opposite was shown for L. monocytogenes. In this 
species low c-di-AMP levels destabilize the bacterial cell wall and therefore promote 
cell lysis. Consequently, bacterial DNA and other molecules are released into the host 
cytosol and lead to a strong immune response [74]. This shows that c-di-AMP acts as a 
PAMP (pathogen-associated molecular pattern) triggering the host immune response. 
However, the effects of c-di-AMP up- or down-regulation on the bacteria, as well as on 
the host, differ in a species specific manner. 
2.8.2 SENSING OF C-DI-AMP BY EUKARYOTES 
In order to react to the PAMP c-di-AMP, the immune system needs a suitable 
pattern recognition receptor (PRR) to initiate an immune reaction. STING (stimulator 
of interferon genes) as well as the DEAD box helicase DDX41 were identified to sense 
c-di-AMP. STING comprises an N-terminal transmembrane domain anchoring the 
protein in the membrane of the endoplasmic reticulum, and a C-terminal ligand 
binding domain. After binding of an activating ligand, STING relocates to punctuate 
perinuclear vesicular compartments where it recruits and activates the kinase TBK1. 
TBK1 in turn phosphorylates IRF3, which activates transcription of type I interferons 
(reviewed e.g. in [90,91]). It was shown that STING is essential for interferon 
expression in response to infection with L. monocytogenes, Chlamydia trachomatis and 
M. tuberculosis, all of these pathogens producing c-di-AMP [85,92,93]. Indeed, cyclic 
dinucleotides, such as c-di-AMP, c-di-GMP and cGAMP were identified to bind to the C-
terminal domain of STING and activate the protein [94,95]. Upon binding of the 
37 
 
nucleotides, the two C-terminal domains of dimeric STING move closer together and 
form a lid closing the binding pocket (Figure 21) [96]. Still, the exact mechanism of 
STING activation is not understood. Interestingly, STING recognizes not only bacterial 
cyclic dinucleotides, but is also activated by an endogenous signal. The cytosolic DNA 
sensor cGAS synthesizes non-canonical 2′-5′cGAMP, which serves as an activator of 
STING, in response to binding to double stranded DNA derived from pathogens or 
cellular damage [97]. Therefore STING acts as a direct sensor of cyclic dinucleotides 
produced by pathogenic bacteria, as well as a link between cytosolic DNA sensing and 
the subsequent immune response. Like this, STING integrates two different ways of 
pathogen recognition making it a key protein in innate immune response. 
 
In addition to STING, a second PRR for c-di-AMP was identified – the DEAD 
box helicase DDX41. This protein senses not only c-di-AMP and c-di-GMP, but also 
DNA, with its DEAD box domain [98,99]. Similar to STING, knockdown of DDX41 
results in reduced interferon expression in response to c-di-AMP, c-di-GMP and DNA, 
as well as pathogenic bacteria such as L. monocytogenes and M. tuberculosis [85,98,99]. 
Moreover, DDX41 was shown to co-localize and interact with the transmembrane 
domain of STING via its DEAD box domain after activation with DNA or cyclic 
dinucleotides [98,99]. DDX41 and cGAS/STING seem to have a similar function and it 
is not entirely understood how the interplay between both pathways works. DDX41 
binds c-di-GMP with higher affinity than STING and might therefore have a function 
upstream of STING [99]. Clearly the DDX41 pathways and its interaction with STING 
need to be studied further to understand how c-di-AMP sensing by the immune 
system works in detail. Interestingly, c-di-AMP was shown to act as an adjuvant when 
co-administered with an antigen, suggesting another medically relevant function of 
this molecule [100].  
Figure 21: Dimeric C-terminal domain of human STING in apo (blue) and c-di-GMP 
bound (purple) state, c-di-GMP is shown as sticks (PDBs 4f5e and 4f5d [96]) 
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In this publication, the reaction mechanism of T. maritima DisA and an 
inhibitor of this enzyme are described. The active site of DisA shows to be highly 
conserved when compared to different DAC domain proteins, and several amino acids 
essential for the reaction to take place were identified. The crystal structures of DisA 
in complex with non-reactive substrate analogs as well as the reaction product c-di-
AMP show the coordination of the nucleotides and the catalytically essential metal ion. 
The comparison of the different reaction states reveals that DisA does not undergo 
movements during the reaction cycle; therefore DisA catalyzes the reaction by 
positioning of the two ATP molecules in the correct orientation. Presumably, the c-di-
AMP synthesis rate is limited by the narrow tunnels connecting the active sites to the 
surface of the protein, making it difficult for c-di-AMP to exit the active site. In vitro 
activity assays support these structural findings. Additionally, the non-reactive 
substrate analog 3′-dATP was found to act as a potent competitive inhibitor of DisA. 
Since c-di-AMP is essential in DAC domain containing bacteria, c-di-AMP pathways 
might be promising targets for antimicrobial therapy. 
 
Author contribution 
I purified DisA, crystallized it in complex with 3′-dATP/Mn2+ and c-di-AMP and 
solved and interpreted the structures. Furthermore, I analyzed the oligomeric state of 
DisA by size-exclusion chromatography, static light scattering and SAXS. Additionally, 
I investigated the activity of different mutant proteins I generated and tested the 
inhibitory effect of 3′-dATP on DisA. I wrote the manuscript together with G. Witte. 
Experimental design and data analysis was supported by G. Witte. 
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Summary statement: 
Structures of T. maritima DisA protein in different reaction states describe the di-adenylate-
cyclase reaction and the possibility of its inhibition. We conclude that the mechanisms of 
cyclic-di-AMP synthesis and its inhibition are conserved among different DAC enzymes 
and bacterial species. 
 
 
 
ABSTRACT 
The identification of the essential bacterial second messenger cyclic-di-AMP synthesized 
by the DNA-integrity scanning protein DisA opened up a new and emerging field in 
bacterial signaling. To further analyze the di-adenylate cyclase reaction catalyzed by the 
DAC domains of DisA, we crystallized Thermotoga maritima DisA in presence of different 
ATP analogs and metal ions to identify the metal binding site and trap the enzyme in pre- 
and post-reaction states. Through structural and biochemical assays we identified important 
residues essential for the reaction in the active site of the DAC domains. Our structures 
resolve the metal binding site and thus explain the activation of ATP for the DAC reaction. 
Moreover, we were able to identify a potent inhibitor of the DAC domain. Based on the 
available structures and homology to annotated DAC domains we propose a common 
mechanism for c-di-AMP synthesis by DAC domains in c-di-AMP producing species and a 
possible approach for its effective inhibition. 
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INTRODUCTION 
Nucleotide second messengers are widely spread throughout all domains of life. Bacteria in 
particular are known to use cyclic AMP, cyclic GMP, cyclic-di-GMP and (p)ppGpp in 
order to regulate the most different signaling pathways. In 2008, however, an additional 
secondary messenger was found: cyclic-di-AMP (c-di-AMP). C-di-AMP was initially 
identified in the crystal structure of the Thermotoga maritima sporulation checkpoint 
protein DNA integrity scanning protein A (DisA) [1], and was subsequently shown to be 
produced by a variety of enzymes containing a diadenylate-cyclase (DAC) domain. DAC 
domain proteins are mainly found in Gram-positive bacteria belonging to the phyla 
Firmicutes and Actinobacteria, including pathogenic bacteria such as Listeria 
monocytogenes or Staphylococcus aureus. The DAC prototype protein DisA forms a 
homooctameric complex, composed of two head-to-head tetrameric rings. The catalytic 
active sites are located at the interface between the two tetramers, whereby two opposing 
monomers form one reaction center. These DAC domains are connected to the C-terminal 
DNA-binding HhH motifs by a long spine consisting of three antiparallel α-helices.  
So far little is known about the mode, function and regulation of bacterial c-di-AMP 
signaling. DisA was found to bind to branched DNA, such as replication intermediates or 
stalled replication forks, and its enzymatic activity is thereupon inhibited, suggesting a role 
in DNA-damage signaling [1, 2]. In agreement with these findings, it was shown that 
reduced c-di-AMP levels cause a delay in sporulation in Bacillus subtilis, whereas an 
elevated c-di-AMP concentration promotes sporulation [3]. Additionally, in B. subtilis 
CdaS was identified as a DAC domain protein expressed only during sporulation. The third 
DAC protein in B. subtilis, CdaA, is activated through interaction with CdaR and is 
presumably involved in control of cell wall biosynthesis [4]. Additional studies showed that 
c-di-AMP is involved in the regulation of cell-wall characteristics and cell size in S. aureus 
and B. subtilis [5, 6]. Although the DAC domain is widespread, the pathways regulated by 
c-di-AMP are so far not well understood. A genome-wide screen identified several proteins 
in S. aureus (KtrA, CpaA, KdpD and PstA) that act as c-di-AMP receptors, thereby linking 
c-di-AMP to potassium transport [7, 8]. Very recently, the mode of c-di-AMP recognition 
by PstA/DarA, which is structurally related to the class of PII-like proteins, was elucidated 
[9-12] suggesting that additional cellular processes are regulated by c-di-AMP. Moreover, 
it was shown that c-di-AMP is a high affinity ligand for the ydaO riboswitch, explaining 
why c-di-AMP affects such a wide range of processes and linking c-di-AMP to the 
regulation of gene expression involved in peptidoglycan synthesis, germination and 
osmotic shock response in bacteria [13, 14]. Although the details of c-di-AMP signaling are 
poorly understood, it is nevertheless obvious that the cellular levels of c-di-AMP need to be 
tightly regulated. Total knockouts of DAC domain proteins in B. subtilis, L. monocytogenes 
and S. pneumoniae are lethal [6, 15, 16]. Similarly, an increase or decrease in c-di-AMP 
concentrations by overexpression or knockouts of DAC domain proteins or c-di-AMP 
degrading phosphodiesterases, respectively, severely impairs bacterial growth and affects 
the virulence of pathogenic bacteria [4, 15, 16]. More specifically, it was shown that a 
decrease of the cellular c-di-AMP concentration renders bacteria more sensitive towards β-
lactam antibiotics [6]. Based on this, DAC domain proteins might prove to be promising 
targets for antibiotic therapies. 
In this study we have structurally analyzed the reaction mechanism of T. maritima DisA for 
the synthesis of c-di-AMP. We crystallized DisA in presence of different substrate analogs 
and metal ions, and are thus able to show the pre- and post-catalytic states of the reaction 
cycle. We were able to pinpoint the essential divalent cation binding site and identified 
catalytically important residues. Using in vitro activity assays we analyzed the impact of 
mutations in the active site. We were additionally able to identify a potent, commercially-
available DAC inhibitor. A structural- and sequence-based comparison of the active sites of 
known DAC domains suggests that our findings can probably be directly transferred to 
other c-di-AMP producing enzymes and help to understand their activity and regulation. 
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EXPERIMENTAL PROCEDURES 
Cloning, expression and protein purification 
His-tagged T. maritima DisA was cloned and recombinantly expressed as reported 
previously [1]. Primers used for protein mutant generation are included in the 
supplementary data (supplementary table S1). For protein purification cells were lysed by 
sonication in buffer A (50 mM Tris-HCl, 300 mM NaCl, 10 mM imidazole, pH 8.0). After 
centrifugation, the supernatant was applied to a Ni-NTA column (Qiagen) and extensively 
washed with buffer A and buffer W (50 mM Tris-HCl, 1 M NaCl, 20 mM imidazole, pH 
8.0). Protein was eluted using buffer B (50 mM Tris-HCl, 300 mM NaCl, 250 mM 
imidazole, pH 8.0) and DisA-containing fractions were pooled and dialyzed against SEC 
buffer (20 mM Tris, 200 mM NaCl, pH 8.0). The protein was applied to a Superdex 200 
preparative-grade size-exclusion column (GE Healthcare) and the fractions were analyzed 
by SDS-PAGE. Fractions containing only DisA were pooled and concentrated. The protein 
was flash-frozen in liquid nitrogen and stored at -80°C until usage. 
 
Crystallization 
1 µL of DisA (8 mg mL-1) in SEC buffer with 2 mM of nucleotide and 20 mM MgCl2 was 
mixed with 1 µL of reservoir solution (30 - 32.5 % (v/v) MPD, 200 mM ammonium acetate 
and 100 mM Tris-HCl pH 8.0 - 8.3). Crystals were grown within 7 days at 15°C through 
hanging-drop vapor diffusion. Reservoir solution containing 35 % (v/v) MPD was used as 
cryo-protectant prior to flash-cooling crystals in liquid nitrogen. For crystals containing 
manganese, 0.2 M MnCl2 was added to the cryo-solution and crystals were soaked for a few 
seconds. 
 
Crystallographic data collection, processing and refinement 
Diffraction data were collected at the beamlines SLS X06SA (Paul-Scherrer Institute, 
Villigen, Switzerland) and PETRA-3 P14 (EMBL c/o DESY Hamburg, Germany) at 100K. 
Diffraction data were processed using XDS and XSCALE [17]. Molecular replacement was 
performed using the apo DisA structure (PDB code 3c1z) as a search model in PHASER 
[18] within the CCP4 suite [19]. Structure refinement comprised automatic refinement steps 
using PHENIX [20] and manual building in COOT [21]. All structures show typical 
statistics for the resolution (Table 1). The coordinates and structure factors have been 
deposited in the PDB with the accession codes 4yvz, 4yxj and 4yxm. Figures of crystal 
structures were generated using PyMOL [22], the tunnels shown in figure 3A were 
computed and displayed with CAVER Analyst [23]. 
 
Small-angle X-ray scattering (SAXS) 
SAXS data were collected at EMBL/DESY Hamburg beamline X33. Protein samples after 
size exclusion chromatography and centrifugation were measured at different 
concentrations between 1 and 5 mg mL-1. Before and after each sample the corresponding 
buffer was measured and used for buffer correction. No sample showed signs of 
aggregation or radiation damage and scattering data were processed and analyzed using 
programs of the ATSAS package [24] as described e.g. in [25]. Theoretical scattering 
curves of crystal structures were calculated using CRYSOL [26]. 
 
Size-exclusion coupled static light scattering (SEC-RALS) 
Size-exclusion coupled static light scattering was performed using an ÄKTAmicro system 
(GE Healthcare Life Sciences) equipped with a RI-device and right-angle laser light 
scattering detector (RALS, Viscotek/Malvern Instruments) with a Superdex S200 10/300 
size-exclusion column (GE Healthcare). BSA (66 kDa) was used as standard protein for 
calibration. Analysis of data was performed using the Viscotek Software OmniSEC. 
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DAC activity assays 
Photometric di-adenylate-cyclase assays were performed similar to [27] in an optimized 
reaction buffer (50 mM glycin/NaOH pH 9.5, 50 mM NaCl, 10 mM MgCl2, 0.3 mM ATP, 
0.1 mU yeast pyrophosphatase (Thermo Scientific)) in a total volume of 50 µL. The ATP 
concentration was optimized in order to perform all assays under substrate saturating 
conditions. The inhibitor 3′-dATP (Jena Biosciences) was used in the concentrations 
indicated (0-150 µM). The reactions were started by addition of 24 nM T. maritima DisA 
(monomer concentration) and incubated at 60°C for 30 min. Reactions were stopped by 
addition of 100 µL BIOMOL Green reagent (Enzo) and absorbance at 620 nm was 
measured after 15 min in a platereader (Tecan M1000 Pro). The absorbance of a control 
without DisA was subtracted in order to calculate normalized activities. At least three 
independent experiments of all activity assays were performed to calculate standard 
deviations. The IC50 was determined using Prism (GraphPad Software). 
 
 
RESULTS AND DISCUSSION 
The DAC domain 
The DAC domain is so far the only fold that has been show to specifically catalyze the 
reaction of two ATP molecules to c-di-AMP and both, its active site residues and fold, are 
highly conserved. Figure 1A shows a sequence comparison of the prototype T. maritima 
DisA N-terminus and the three encoded DACs of B. subtilis (DisA, CdaA and CdaS), in 
addition to DAC domains from various other species previously described in the literature. 
In good agreement with data from [1, 28], highly conserved residues of two opposing 
subunits, such as the DGA (residues 75-77, numbering referring to T. maritima DisA) and 
RHR motifs (residues 108-110), form the reaction center. 
Previous in vivo experiments by Oppenheimer-Shaanan et al. showed that GFP-labeled 
DisA D75N, demonstrated to be inactive in DAC assays, abolished foci formation in B. 
subtilis as observed for the wildtype before [2]. This suggests that DisA D75N might not 
form the octamers essential for its activity [3]. We crystallized the TmaDisA mutant D75N 
and both the overall structure of DisA D75N and crystal packing are virtually identical to 
the wild-type DisA protein. To analyze the oligomeric state of DisA D75N in solution we 
performed size-exclusion chromatography coupled light scattering (SEC-RALS, Fig. 1B) 
and small-angle X-ray scattering (SAXS) experiments (Fig. 1C). DisA D75N elutes in a 
single peak with a molecular weight determined by SEC-RALS of MwSECRALS D75N = 339 
kDa, showing that the mutant protein still forms an octamer under the conditions used (Mw 
theoretical octamer = 336 kDa). The molecular parameters determined by SAXS (Mw SAXS = 360 
kDa, Rg = 5.5 ± 0.1 nm) and the shape of the scattering curve are only compatible with a 
homogenous octameric species (Rg theoretical, unhydrated = 5.34 nm). Thus, DisA D75N is still 
octameric in solution and the inactivity is instead due to changes in the active site.  
 
Pre-reaction states 
We solved the structure of DisA in complex with a non-reactive ATP analog (3′-dATP, 
cordycepin triphosphate) and MnCl2 in order to trap the enzyme in the pre-reaction state 
and to identify the metal binding site. Manganese was chosen as a substitute for magnesium 
to allow us to identify the metal ion and distinguish it from well-coordinated water 
molecules by its anomalous signal. The ion is octahedrally coordinated with all six 
coordination positions occupied by oxygen ligands (Fig. 2A). The three phosphate groups 
from 3′-dATP together with Asp75 from the adjacent subunit and two water molecules are 
all located between 2.0 and 2.5 Å from the manganese, in good agreement with its ideal 
coordination distance. The 3′-dATP phosphate groups are bent around the metal ion, with 
the β- and γ-phosphate being additionally held in place via hydrogen bonds with Arg108 
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and His109 from the highly conserved RHR motif and Arg130. Thr107 interacts with the α-
phosphate and additionally contacts 7N of the adenine (also contacted by Leu94), and 
Thr111 forms a hydrogen bond with 6N. The ribose is contacted at O4′ by Arg108 and at 2′-
OH by backbone interactions with Gly76. The γ-phosphate is mainly polarized by Ser127, 
Arg128 and Arg130 facilitating the nucleophilic attack on the α-phosphate (see also 
supplementary table S2 and figure S1).   
In summary, the pre-reaction state shows a highly coordinated arrangement of the two ATP 
(-analogs) in almost optimal distance for the nucleophilic attack of the 3′-OH on the α-
phosphate of the neighboring ATP. The α-phosphate is well coordinated and additionally 
stabilized by the positive dipole of helix α5. In good agreement with these observations, 
point mutations of selected active site residues (Asp75, RHR motif 108-110, Arg130, 
Thr107, Thr111) lead to significantly decreased DAC activity of DisA in vitro (Fig. 2B and 
S2), proving the biological relevance of the structural features observed. 
As 3′-dATP lacks the attacking hydroxyl group we crystallized DisA in the presence of the 
non-hydrolyzable ATP analog ApCpp (adenosine-5′-[(α,β)-methyleno]triphosphate). The 
structure of the DisA-ApCpp complex is highly similar to the structure with 3′-dATP 
(overall rmsd 1.2 Å) and only the phosphate groups adopt a slightly different orientation 
(Fig. 2C), presumably because the ApCpp complex structure lacks the metal ion 
coordinated by the phosphates. The distance between the 3′-hydroxyl group and the α-
phosphate of 4.6-4.9 Å is consequently relatively large. The α-phosphate, however, 
probably moves closer towards the 3′-OH when interacting with a metal ion (as observed in 
the 3′-dATP structure), facilitating the nucleophilic attack, as implied by the structure with 
3′-dATP and MnCl2. 
Interestingly, our attempts to crystallize DisA D75N, shown to be fully inactive in DAC-
assays, with the native substrate ATP/Mg2+ unexpectedly produced crystals with 
unambiguous density for c-di-AMP bound in the active site (Fig. 2D). Obviously, the much 
longer time-scale of crystallization (compared to in vitro assays) allows the reaction to 
occur to a significant extent. Probably the correct orientation of the ATP nucleotides still 
takes place due to the high number of stabilizing interactions within the DAC site, even 
though the main interaction partner for ion-coordination (carboxyl-group of Asp75) is 
missing. Apparently, even imperfect binding of the nucleotides and their respective 
orientation is sufficient for the reaction to take place on the long time-scale of 
crystallization. 
 
Post-reaction state 
The first structural report of DisA described the product state in which c-di-AMP is bound, 
even though no nucleotide was added to the crystallization condition [1]. This indicates that 
the reaction product is tightly bound in the active site with very slow off-rate kinetics, even 
though c-di-AMP is less well coordinated than ATP, since most interactions in the reaction 
center occur with the three phosphate groups rather than the adenine or sugar moieties (Fig. 
2D and supplementary table S3). In comparison, the product state only shows coordination 
of c-di-AMP by the DGA motif (residues 75-77), Thr107 and Thr111. We analyzed the 
accessible surface and cavities of DisA in order to identify the possible substrate and 
product release paths (Fig. 3A). A likely reason for the slow release of c-di-AMP from the 
active site is the size of the tunnel that leads from the reaction center to the surface. This 
has a bottleneck diameter of approximately 7.8 Å (supplementary figure S3), which is just 
large enough to allow c-di-AMP to pass through. To exit the DisA molecule, c-di-AMP has 
to first move to the center of DisA and then to the side, passing the loop connecting β5 and 
β6 (Arg128-130) of the DAC domain and finally to the surface, covering a total distance of 
approximately 40 Å. In figure 3A one of the possible paths c-di-AMP needs to follow is 
indicated. Since DisA is a symmetric octamer, c-di-AMP from any active site can of course 
exit by any of the eight tunnels. Due to the fact that we only observe snapshots in our 
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crystal structures, we cannot exclude a certain degree of “breathing” of the octameric 
assembly that might lead to other exit pathways. To test for flexibility of DisA we 
calculated a simulation of protein structure fluctuation [29] of one monomer and found only 
small predicted movements in loops on the surface, showing that DisA is very rigid and 
thereby indicating that the tunnels observed in the static crystal structure are probably 
similar in solution (supplementary figure S4). However, upon mutating the three arginine 
residues 128-130 in the loop that c-di-AMP needs to pass to exit the molecule to less bulky 
amino acids (R128-130A), the activity of DisA increases approximately 2-fold, even 
though Arg130 is a major factor in coordination of the γ-phosphate of ATP and the single 
mutation (R130A) is almost completely inactive (Fig. 2B). This indicates that the rate-
limiting step of c-di-AMP synthesis by DisA is not defined by the reaction itself, but rather 
by the accessibility of the active site. 
 
Structural comparison of the DAC reaction states and DAC domains 
A comparison of apo-, pre- and post-reaction states in a superposition shows no major 
structural changes of DisA (Fig. 3B). Based on the structures, no small-scale movements of 
domains or loops can be observed, supporting the idea that binding and coordination of 
ATP/Mg2+ seems to be sufficient for the DAC reaction to take place. To test our hypothesis 
that DAC domains share this reaction site we superimposed the DAC domains of DisA (3′-
dATP complex) and the recently reported structure of L. monocytogenes CdaA in complex 
with ATP [28] (Fig 3C). Both DAC domains show virtually identical arrangement of motifs 
and also the nucleotides superimpose very well (rmsd 1.25 Å) as previously observed for a 
DAC domain from B. cereus [1]. The CdaA construct used in [28] obviously does not form 
active dimers in DAC-to-DAC orientation and thus crystallized in presence of the native 
substrate ATP/Mg2+, thereby supporting our pre-reaction state structure containing 3′-dATP 
(see above). 
 
Inhibition of DisA 
C-di-AMP synthesis is essential for bacteria, as shown through numerous failed attempts to 
knock out all DAC domain proteins in different species. Similarly, a decrease of the cellular 
c-di-AMP concentration renders bacteria more sensitive towards β-lactam antibiotics [6]. 
These findings suggest that DAC domain proteins may be promising targets for antibiotic 
therapy. Cordycepin (3′-deoxy-adenosine) is a natural adenosine analog produced by the 
fungus Cordyceps, which has been identified to offer a large variety of medically beneficial 
effects, such as anti-tumor, anti-inflammatory and anti-bacterial effects (e.g. reviewed in 
[30]). Inside the cell, cordycepin is phosphorylated to 5′-mono-, di- or tri-phosphate and 
subsequently interferes with different essential pathways (e.g. reviewed in [31]). Since 
cordycepin triphosphate (3′-dATP) is a non-reactive substrate analog for DisA that traps the 
enzyme in the pre-reaction state (see above), we investigated its effect on the in vitro DAC 
activity. We found commercially available 3′-dATP to be an effective inhibitor of DisA 
with an inhibitory constant (IC50) of 3 µM when 26 nM DisA and 300 µM ATP were used 
(Fig. 4A). Interestingly, it has already been shown that cordycepin isolated from Cordyceps 
fungi is able to inhibit growth of Clostridium species with similar efficiency as 
conventional antibiotics such as tetracycline and chloramphenicol [32]. This antibacterial 
effect is likely due to cordycepin affecting various essential cellular pathways as a 
nucleoside analog, probably also including those that require DAC activity. 3′-dATP is the 
second DisA inhibitor to be identified following bromphenol thiohydantoin (TH) [33]. In 
the bromphenol-TH activity assays significantly different concentrations of DisA and ATP 
were used for determination of the inhibitory constant, thus the inhibitory effectiveness of 
3′-dATP versus bromphenol-TH cannot be directly compared between our study and [33]. 
The two inhibitors are furthermore likely to have different modes of action. The crystal 
structure shows that while 3′-dATP is a competitive inhibitor that binds in the same 
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position as ATP (Fig. 2A), bromphenol-TH seems to be an allosteric inhibitor that binds 
close to a tryptophan residue. The exact binding site for bromphenol-TH remains unknown 
and while it might be specific for DisA, the DAC domains from different proteins are 
highly conserved in their active site residues and we thus postulate that 3′-dATP has the 
potential to inhibit not only DisA but also other DAC domain proteins. 
 
Hypothesis on the regulation of DisA 
DisA recognizes recombination intermediate DNA structures via its HhH motifs and upon 
binding these DNAs displays strongly reduced or abolished DAC activity. The current 
model for the down-regulation of DisA is based on the fact that the HhH domains at the 
DisA C-terminus need to rearrange in order to be able to bind to DNA. This rearrangement 
and rotation of the DNA-binding motif is probably translated by the helical spine domain 
leading to changes in the orientations of the DACs and thus to their inactivation. So far we 
were not able to crystallize a DisA-DNA complex or identify these DisA/Holliday-junction 
complexes in electron microscopy, making it hard to predict which molecular 
rearrangements might lead to signaling or loss of DAC activity. In order to obtain a smaller 
version of DisA we created a F57R mutant of TmaDisA that was supposed to form 
tetramers, as the F57R mutation disturbs the DAC dimer-interfaces. However, depending 
on the salt concentration this mutant also forms lower oligomeric species, as observed in 
SEC experiments (Fig. 4B). This finding is in good agreement with the interactions 
between the helical spine domains being mainly ionic and suggests that once the DAC 
domains are disrupted by HhH-induced structural changes upon DNA binding, DisA might 
become unstable and dissociate. Dissociation and/or degradation of DisA as a result of the 
DNA complex formation would be a reasonable explanation of the measurable decrease in 
c-di-AMP levels in the cells upon DisA sensing DNA-damages [3] as it would affect more 
than one DisA. It would probably be impossible for the cell to sense the presence of 
recombination intermediates by just a single DisA being down regulated, while 25-50 other 
DisA-octamers [34, 35] and also CdaA and CdaS remain active in the cell. Of course, we 
might lack effector proteins that specifically recognize the DisA-DNA complex and 
amplify the signal, e.g. by RadA interaction [36, 37] or up-regulation of a c-di-AMP 
phosphodiesterase. However, the exact mechanism of regulation remains to be shown, as 
there is currently no structural information about the DisA-DNA or proposed DisA-RadA 
complexes. 
 
In summary, our structural and biochemical analysis provides a model for the reaction 
mechanism of DNA-integrity scanning protein A that can probably be transferred to any 
other bacterial DAC domain protein because of structural and sequence similarity. 
Moreover, we were able to show that a commercially-available nucleotide analog that has 
also been shown to affect various other essential processes in the cell is also a potent 
inhibitor of c-di-AMP synthesis. The fact that c-di-AMP levels have been reported to 
influence e.g. MRSA antibiotic resistance renders the c-di-AMP pathway an interesting 
new target for antimicrobial therapy.  
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Table 1: Crystal parameters, data collection and refinement statistics 
Crystal data TmaDisA  
3′-dATP/Mn2+ 
TmaDisA 
ApCpp 
TmaDisA D75N 
c-di-AMP 
   Space group P4212 P4212 P4212 
   Molecules per ASU 2 2 2 
   Unit cell parameters    
      a,b,c (Å) 107.49, 107.49, 168.79 108.25, 108.25, 166.40 108.55, 108.55, 165.92 
      α,β,γ (°) 90, 90, 90 90, 90, 90 90, 90, 90 
Data collection statistics    
   Diffraction source PETRA3-P14 SLS X06SA SLS X06SA 
   Wavelength (Å) 1.23953 1.00149 1.00000 
Data processing statistics    
   Resolution range (Å) 
   No. of observed reflections 
168.8-2.50 (2.56-2.50) 
497086 (33161) 
50-2.55 (2.61-2.55) 
186053 (6649) 
50 -2.25 (2.31-2.25) 
625199 (45367) 
   No. of unique reflections 65492 (4613) 32830 (2248) 47778 (3483) 
   Completeness (%) 99.6 (94.5) 99.2 (93.9) 100 (100) 
   Multiplicity 7.6 (7.2) 5.7 (3.0) 13.1 (13.0) 
   Mean I/σI 15.9 (2.8) 15.5 (2.1) 18.3 (1.6) 
   Rmeas (%) 11.6 (113.3) 14.7 (73.7) 11.9 (217.2) 
Refinement    
   Resolution (Å) 
   No. of used reflections 
168.8-2.50 
65492 
48.41-2.55 
32808 
49.28-2.25 
47724 
   Rwork (%) / Rfreea (%) 16.42 / 21.89 18.99 / 24.33 18.86 / 23.73 
   No. of non H-atoms (total) 5775 5840 5797 
      Protein  5600 5592 5602 
      Ligand  60 (3′-dATP) / 4 (Mn2+) 62 44 (c-di-AMP) / 8 (MPD) 
      Water 111 186 143 
   Average B factors  (Å2)    
      Wilson B factor 53.7 46.0 54.8 
      overall 51.5 47.3 60.3 
      Protein 52.8 46.2 55.9 
      Ligands / Water 3′-dATP 34.9 
Mn2+ (active site) 44.1 
Mn2+ (surface) 97.6 
waters 46.3 
ApCpp 50.0 
waters 46.7 
c-di-AMP 48.7 
MPD 85.9 
waters 55.2 
  R.m.s. deviations    
      Bond lengths (Å) / angles (°) 0.008 / 1.103 0.009 / 1.125 0.007 / 1.046 
  Ramachandran plot analysis    
      Favoured (%) 97.8 97.0 98.0 
      Allowed (%) 2.2 3.0 2.0 
      Disallowed (%) 0 0 0 
  PDB identifier 4yvz 4yxj 4yxm 
 
Values in parentheses are for the highest resolution shell 
afor the Rfree calculations 5% of the total number of reflections was used. 
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FIGURE LEGENDS 
 
Figure 1: DAC domain conservation and overall characteristics of DisA 
A) Sequence alignment of DAC domains of selected DAC proteins from various 
organisms. Residues in TmaDisA that interact with substrate/product are marked by 
asterisks.  
B) TmaDisA D75N is an octamer in solution as determined by SEC-RALS (MwSECRALS 
D75N = 339 kDa) 
C) Small-angle X-ray scattering of TmaDisA D75N (blue dots show the measured 
scattering data, black curve represents the theoretical scattering curve of an octameric DisA 
calculated with CRYSOL [26]). 
 
Figure 2: DisA active site 
A) Pre-reaction state of the cyclase reaction with 3′-dATP and a manganese-ion in the 
active site. The Mn2+ ion is shown with its anomalous difference density at 4σ, the two 
facing DAC domains are shown in light and dark blue. Some residues have been omitted 
for clarity. 
B) In vitro di-adenylate cyclase assays with normalized activities of selected active site 
mutations. Error bars represent standard deviations of n = 3 independent experiments. 
Mutations of amino acids interacting with the substrate or the metal ion lead to a strong 
decrease in activity, while easier accessibility of the active site results in higher activity 
(R128-130A). 
C) Superposition of the DisA/3′-dATP (blue, 3′-dATP shown as lines) and the 
DisA/ApCpp-structure (grey, ApCpp shown as sticks). The Mn2+ ion has been omitted for 
clarity. Note that the ApCpp structure does not contain a divalent metal ion and thus the 
triphosphates are in elongated conformation.  
D) Close-up of the active site of the TmaDisA D75N mutant crystallized in presence of 
ATP/Mg2+. Even though the D75N mutant is inactive in in vitro assays, c-di-AMP is 
present in the active site (c-di-AMP with annealed composite omit map at 1σ) 
 
Figure 3: Reaction states of DisA 
A) DAC domains in the octameric assembly with tunnels shown in blue (calculated with 
CAVER [23]), the RRR loop (residues 128-130) shown in black and c-di-AMP in red. 
Orange arrows show one possible path c-di-AMP has to follow in order to exit the active 
site. 
B) Superposition of apo- (black), pre- (3′-dATP blue, ApCpp grey) and post-reaction state 
(green) of TmaDisA monomers (left panel) and their per-residue rmsd compared to the apo-
structure (right panel). Whereas almost all residues have very low rmsds with respect to the 
apo-structure, a short loop region on the surface (indicated by an asterisk) has slightly 
higher deviations, probably because of flexibility.  
C)  Superposition of L. monocytogenes CdaA (green) and TmaDisA (blue) DAC domains 
bound to ATP/Mg2+ and 3′-dATP/Mn2+, respectively (rmsd 1.25 Å) 
 
Figure 4: DisA inhibition and regulation 
A) Inhibition of c-di-AMP synthesis by the non-reactive nucleotide 3′-dATP under 
substrate saturating conditions (300 µM ATP, 26 nM DisA) shows an IC50 of 3 µM (R2 = 
0.997). Error bars represent standard deviations of n = 4 experiments.  
B) TmaDisA F57R mutant shows salt dependent dissociation. The mutant (blue no salt 
buffer, green 10 mM NaCl buffer) elutes at higher volumes from a Superose 6 PC 3.2/30 
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column compared to wild-type TmaDisA (black curve) and thus is destabilized by salt, 
suggesting a dissociation from e.g. tetramers to monomers.  
 
 
 
 
 
 
 
 
 
Figure 1: DAC domain conservation and overall characteristics of DisA 
  
52 
 
 
 
Figure 2: DisA active site 
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Figure 3: Reaction states of DisA 
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Figure 4: DisA inhibition and regulation 
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3.2 C-DI-AMP RECOGNITION BY S. AUREUS PSTA 
Müller, M., Hopfner, K.-P. and Witte, G. (2015) c-di-AMP recognition by Staphylococcus 
aureus PstA. FEBS letters. 589, 45-51 
 
DOI: 10.1016/j.febslet.2014.11.022 
http://www.febsletters.org/article/S0014-5793(14)00827-8/ 
 
This publication describes structurally and biochemically how the c-di-AMP 
receptor PstA from S. aureus binds to its ligand c-di-AMP. PstA is the first signal 
transduction protein specifically recognizing c-di-AMP to be analyzed in detail. 
Biophysical methods were applied to characterize the oligomeric state of the protein, 
which proved to be a trimer. Additionally, strong and specific binding of c-di-AMP by 
PstA was kinetically analyzed by surface plasmon resonance experiments and binding 
studies with radioactively labeled nucleotides. Finally, the crystal structures of the 
apo, as well as the c-di-AMP bound state of the protein were solved and revealed 
structural changes upon ligand binding.  
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4 DISCUSSION 
C-di-AMP was discovered only very recently and there are still more open 
questions than answers on how synthesis, signaling and degradation of this second 
messenger work. In the following chapters some of these poorly understood aspects 
and possible explanations will be described. 
4.1 HOW IS C-DI-AMP SYNTHESIS REGULATED? 
So far, DisA is the only DAC domain protein which’s c-di-AMP synthesis 
mechanism was analyzed in detail. However, the catalytically active residues of DAC 
domains are highly conserved between different proteins and species and a similar 
reaction mechanism can be assumed for all of them. Still, the regulation of the 
enzymatic activity differs between the three classes of DAC proteins – DisA, DacA and 
DacB – and is far from being understood.  
The rate limiting step of the cyclase reaction seems to be product release 
rather than the reaction itself for DisA. This is due to the narrow tunnels connecting 
the active sites of the protein to the surface, which are just large enough for c-di-AMP 
to pass through [40]. However, this is only the case for octameric DisA and not for 
DacA or DacB, which possess a different domain organization. In order to form a 
functional active site, two DAC domains need to come into close proximity in a head-
to-head orientation. This is true for DisA, which forms a very stable and rigid octamer 
with four active sites in its center. It was shown that DacA lacking its transmembrane 
helices forms an active dimer in solution, even though it does not in the protein 
crystal, indicating a rather unstable dimerization [34]; the oligomeric state of the full-
length protein was not studied so far. However, maximal activity of DacA is only 
obtained after interaction with its activator CdaR, and even then DacA is less active 
than DisA [31]. The activation of DacA by CdaR might be due to stabilization of the 
active dimer conformation or through structural changes in the active site. Still, the 
conditions for c-di-AMP synthesis are less ideal than in DisA, as DisA is more active 
than DacA. Furthermore, the function of the transmembrane helices and whether they 
have an influence on the enzymatic activity is still unknown. Structural analysis of full-
length DacA and the DacA-CdaR complex will answer these open questions on c-di-
AMP synthesis by DacA. 
The activity of DacB is negatively regulated by its N-terminal α-helical YojJ 
domain, as point mutations and deletion of this domain result in strongly increased 
activity [31,36]. The uncharacterized DacB homolog BC_4920 from B. cereus 
crystallizes in a way that the YojJ domains interact with each other and the DAC 
domains do not form functional dimers (Figure 22). Based on this, it was suggested 
that DacB oligomerizes in a similar inactive hexameric conformation in solution. 
However, the structure of the oligomer is not compact but widely expanded and it 
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seems very unlikely that a DacB 
oligomer is present in this or a similar 
conformation in solution. It remains to 
be shown whether the interactions 
observed in the crystal structure are 
only due to crystal packing or indeed 
represent the inactive state of DacB as 
present in solution. Furthermore, the 
mechanism of DacB activation is 
unknown. In order to form a functional 
active site the DacB oligomer needs to 
undergo drastic rearrangements upon a 
yet unknown stimulus. To answer these 
open questions, first of all the 
oligomeric state of DacB in solution 
needs to be studied in more detail and 
by suitable techniques, as the protein is rather unstable and tends to aggregate. 
Moreover, the mode of DacB activation by interaction partners, small molecule ligands 
or different mechanisms needs to be studied to fully understand the function of this c-
di-AMP synthase. 
DisA is constitutively active and is inactivated by interaction with branched 
DNA or RadA [21,29]. Branched DNA structures occur for example at stalled 
replication forks or during homologous recombination and inhibition of DisA serves 
as a signal for the cell to stop sporulation until the DNA damage is repaired [20]. DisA 
comprises a C-terminal HhH domain responsible for DNA binding. Since DisA forms a 
symmetrical octamer, four DNA binding domains are on each side of the oligomer 
(Figure 23 A). The four-fold symmetry of the HhH domains is ideal for binding to 
holliday junctions. However, comparison with E. coli RuvA [101], a protein involved in 
holliday junction processing, shows that the HhH domains of DisA need to rearrange 
in order to allow DNA binding. One of the loops interacting with DNA is partially 
buried; moreover the DNA would clash with DisA in the conformation present in the 
crystal structure (Figure 23 B). Therefore it is likely that the HhH domains of DisA 
rotate in order to bind to DNA and this rearrangement leads to further structural 
changes resulting in inactivation of DisA. 
Figure 22: Hexamer formation in the crystal of the B. 
cereus DacB homolog; the catalytically essential DGA 
and RHR motifs are highlighted (PDB 2fb5 [37]) 
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So far it is not understood how DisA is inactivated upon binding to DNA. The 
rotation of the HhH domains might be transduced by the helical spine domain and 
finally lead to structural changes in the active site. However, when only one DisA 
octamer binds to a branched DNA structure and is inhibited, the remaining DisA 
molecules are still active and produce c-di-AMP. Therefore the drop in the 
intracellular c-di-AMP concentration would be very small and probably not sufficient 
for the cell to sense it. This is why DNA binding probably triggers other processes 
affecting more than one DisA octamer (Figure 24). One possibility is that DisA 
disassembles. The DisA octamer is very stable in solution and does not show any 
dissociation in size exclusion chromatography or small angle X-ray scattering 
experiments. However, rotation of the HhH domains upon binding to DNA might 
induce further conformational changes disturbing the interactions between the 
monomers. After dissociation of one DisA octamer, another could bind to the branched 
DNA structure and more and more DisA complexes would be successively inactivated. 
Another reason for efficient inactivation of DisA in vivo might be the interaction with 
RadA. DisA and RadA were shown to interact in vivo and overexpression phenotypes 
of DisA can be rescued by overexpression of RadA [29]. However, our own 
unpublished data shows that the interaction is very weak in vitro, when no DNA is 
present. Therefore RadA might be recruited to the DisA-DNA complex rather than to 
DisA alone. Still, the mechanism of DisA inactivation by RadA is not known. RadA 
comprises a LonC protease domain and might therefore degrade DisA. Clearly, the 
function of RadA needs to be studied in more detail to fully understand its interaction 
with DisA. The third possibility of DisA inactivation is the recruitment or activation of 
effector proteins by the DisA-DNA complex. These proteins might e.g. be 
phosphodiesterases, which degrade c-di-AMP in addition to DisA being less active. 
However, there is no experimental evidence for this theory so far. 
Figure 23: (A) HhH domains of octameric T. maritima DisA (PDB 4yvz [40]). (B) T. maritima DisA (HhH 
domains blue) in superposition with the HhH domain of E. coli RuvB (purple) in complex with DNA 
(yellow); PDB 1c7y [101]. 
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Finally, it is unknown how the drop in the c-di-AMP concentration upon DisA 
inactivation is sensed and by which mechanisms it delays sporulation. The c-di-AMP 
receptors identified so far seem not to be involved in sporulation; therefore the key 
protein is probably a receptor that has not been found yet. Moreover, it remains 
unclear how the cell distinguishes between c-di-AMP from different DAC domain 
proteins to initiate the corresponding response. One way might be compartmentation, 
as DacA is associated to the cell membrane and DisA co-localizes with DNA [20]. 
Therefore, DacA might signal cell wall and membrane related issues, while DisA 
signals DNA damage. Nevertheless, diffusion of a small molecule such as c-di-AMP is 
fast and its radius of action therefore covers the whole bacterial cell. Today the 
regulation of c-di-AMP synthesis and its sensing is still poorly understood and future 
studies will hopefully answer these questions. 
4.2 C-DI-AMP RECEPTOR PSTA 
PstA was found to specifically bind c-di-AMP with high affinity in S. aureus, B. 
subtilis and L. monocytogenes. Crystallization studies revealed that PstA adopts a 
trimeric ferredoxin like fold typical for PII proteins. However, poor sequence 
homology, altered ligand binding loops and a different function show that PstA is only 
distantly related to canonical PII proteins [60–63]. The B- and T-loops are swapped in 
length and presumably fulfill complementary functions. The T-loop, which is the 
longer of the two loops in canonical PII proteins and is usually involved in interaction 
with target proteins, comprises only few amino acids in PstA and interacts with c-di-
AMP. On the other hand, the B-loop, which is the longer loop in PstA, might bind to 
downstream targets or signaling proteins. It was suggested that the B-loop becomes 
more ordered in the c-di-AMP bound state; however, the electron density of this 
flexible loop in the corresponding crystal structures is very diffuse and hardly 
Figure 24: Theories on DisA inactivation after binding to DNA 
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interpretable. Moreover, the structure in solution is difficult to analyze and therefore 
unknown. Possibly, the interaction of PstA with its downstream targets does not take 
place via the B-loop, but via the compact head domain of the protein. In this case the 
rearrangement of the T-loop upon c-di-AMP binding might facilitate interaction with 
target proteins. PII(-like) proteins were shown to transduce signals by different 
mechanisms upon binding to small molecule ligands such as ATP or ADP. For example, 
ADP bound E. coli GlnK interacts with the ammonia channel AmtB by insertion of its 
long T-loops into the channel’s pores and thereby blocks it (Figure 25 A) [102]. On the 
other hand, Synechococcus elongatus PII binds to one of its targets, the transcription 
factor activator PipX, mainly via its core, but still the T-loops play an important role by 
forming a ‘cage’ around the three PipX monomers bound simultaneously (Figure 25 B) 
[103]. Finally, Azospirillum brasilense GlnZ in complex with ADP binds to three 
monomers of the nitrogenase regulatory enzyme DraG exclusively via its core domain 
and not by interaction with the B- or T-loops (Figure 25 C) [104]. 
The identification of PstA’s target proteins is most important for correct 
interpretation of the PstA crystal structures; however, no interaction partner of PstA 
was found so far. Even though PstA is neither essential nor universal, all species 
comprising a PstA protein harbor also a DAC, therefore interaction with c-di-AMP is 
likely conserved and important [61–63]. A genetic link between PstA and the 
thymidylate kinase tmk is observed in different organisms, but no experimental 
evidence confirming this possible interaction partner was given so far. Pull-down 
experiments might allow identification of proteins interacting with PstA and reveal 
the signaling pathway this protein is involved in. 
Only two c-di-AMP binding proteins have been crystallized so far – PstA and 
the L. monocytogenes pyruvate carboxylase. However, the c-di-AMP binding sites of 
both proteins are not conserved. The only common feature is that c-di-AMP is bound 
Figure 25: (A) E. coli GlnK in complex with the ammonia channel AmtB (PDB 2nuu [102]). (B) S. 
elongates PII in complex with the transcription factor regulator PipX (PDB 2xg8 [103]). (C) A. brasilense 
GlnZ in complex with the nitrogenase regulatory enzyme DraG (PDB 3o5t [104]). 
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in a surface accessible pocket between two subunits. Still, this observation is not 
sufficient to deduce a general c-di-AMP binding motif or fold. 
It is still not known why c-di-AMP is essential in most bacterial species studied 
so far. The function of c-di-AMP seems to be mainly associated to K+ and cell wall 
metabolism and homeostasis. However, all widely spread c-di-AMP receptors 
identified were shown to be not essential. Therefore the essential receptor is either 
still missing or the sum of all individual parts makes c-di-AMP important. It was 
suggested that c-di-AMP does not activate an essential process but indirectly inhibit a 
toxic mechanism [71]. However, evidence for such a mode of action was only shown 
for L. monocytogenes so far and, what is more, it is still unknown what this toxic 
mechanism might be. Further search for c-di-AMP receptors and more detailed 
investigation of the pathways already identified will reveal the essential mechanism. 
4.3 C-DI-AMP PATHWAYS AS DRUG TARGETS 
The intracellular concentration of c-di-AMP needs to be tightly regulated, as 
increased as well as decreased levels of this second messenger lead to severe 
phenotypes. Moreover, c-di-AMP was found to be essential in all but one species 
studied so far. Furthermore, bacteria with decreased levels of c-di-AMP possess a less 
stable cell wall and are therefore more susceptible towards cell wall targeting 
antibiotics [74,81,83,84]. This is why DAC inhibitors, or similarly PDE activators, 
might prove to have beneficial effects in antimicrobial therapy. DAC inhibitors might 
not be sufficient to kill bacteria efficiently, as strains with conditionally depleted DACs 
are still able to grow slowly. However, those substances might be powerful in 
combination with cell wall targeting antibiotics such as β-lactams.  
3′-dATP is a potent competitive inhibitor of DisA. The substance is derived 
from cordycepin (3′-deoxy adenosine), an adenosine analog produced by the fungus 
Cordyceps. Cordyceps is not only applied in traditional Chinese medicine, but was also 
shown to exhibit various medically beneficial properties in treatment of e.g. cancer 
and inflammatory diseases. Many of the effects observed could be assigned to 
cordycepin. When cordycepin is taken into the cell, it is first phosphorylated to 3′-
dAMP, 3′-dADP or 3′-dATP and subsequently inhibits various enzymes, finally 
inducing apoptosis. Even though the effects of cordycepin, being an ATP analog, are 
rather unspecific, the substance is tested against leukemia in phase 2 clinical trials 
(reviewed e.g. in [105,106]). In addition to the therapeutic potential against e.g. 
cancer, cordycepin was shown to inhibit growth of Clostridium species with similar 
efficiency as tetracycline or chloramphenicol [88]. Cordycepin definitely inhibits 
several different enzymes in bacteria; however, DAC domain proteins are certainly 
among them. 3′-dATP is probably not suitable to be administered as an antimicrobial 
drug, since severe side-effects can be expected due to it interfering with many 
different enzymes. Still, 3′-dATP is commercially available and might therefore be 
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interesting for research purposes. The second DisA inhibitor described is 
Bromophenol-TH [87]. This substance was identified in a kinase inhibitor library and 
acts as an allosteric inhibitor of DisA. Binding of Bromophenol-TH changes 
fluorescence of a tryptophan residue. Unfortunately, the authors failed to mention the 
species their DisA originates from, as for example B. subtilis DisA does not possess any 
tryptophan. Therefore it is not possible to speculate on the mode of inhibition by 
bromophenol-TH by comparison with the T. maritima DisA crystal structure. 
However, the allosteric binding of bromophenol-TH is likely to be specific for DisA, or 
even only for the DisA used by the authors, and does probably not affect other DAC 
domain proteins. 
DAC inhibition is certainly beneficial in many bacterial species, but not all. 
Intracellular bacteria such as L. monocytogenes and M. tuberculosis secrete c-di-AMP 
into the cytosol of their host cells. C-di-AMP is then recognized as a PAMP by STING or 
DDX41 and the immune response is initiated. It was shown that the more c-di-AMP is 
produced and secreted, the stronger is the immune response, measured via the IFN-β 
concentration. This strong immune response leads to efficient killing of the bacteria 
and therefore bacterial strains with high c-di-AMP levels exhibit a less virulent 
phenotype [23,74,76,78,85,89]. Consistently, reduced c-di-AMP levels lead to less IFN-
β production and a more virulent phenotype in M. tuberculosis [76,85]. In contrast, a 
low c-di-AMP concentration results in a destabilized cell wall in L. monocytogenes, 
therefore to more cell lysis and in consequence a strong immune response [74]. 
Therefore increased, as well as decreased levels of c-di-AMP in L. monocytogenes are 
beneficial for the host, while only an increase in the c-di-AMP concentration triggers a 
strong immune response during M. tuberculosis infections. This is why inhibition of 
the PDE instead of the DAC might be promising in therapy against M. tuberculosis. In 
general, bacteria with high intracellular c-di-AMP concentrations are less susceptible 
towards cell wall antibiotics, as the cell wall is more stable; however, they exhibit a 
less virulent phenotype [24,27,30,74–76,78,81,84–86]. The reason for this is not 
entirely understood. In S. pyogenes knockout of the PDE negatively affects the 
virulence factor SpeB and this bacterial strain is therefore less pathogenic in a mouse 
model [75]. In S. pneumoniae knockout of one or both its PDEs leads to almost 100% 
survival of mice, the reason is however unknown [27].  
Depending on the bacterial species, the effects of high or low c-di-AMP 
concentrations obviously differ. C-di-AMP is essential in most bacteria. Moreover, due 
to the cell wall being more stable in high c-di-AMP conditions the bacteria are more 
resistant to cell wall antibiotics and undergo less lysis. Therefore less bacterial DNA 
and other PAMPs are released to trigger an immune response. On the other hand, 
PDEs seems to have a function in virulence factor processing and c-di-AMP itself acts 
as a PAMP. The species specific differences need to be studied in more detail to 
understand where they originate from and how they might be used for specific and 
efficient antimicrobial therapy.  
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